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1.1 Summary 
The primary objective of this thesis was to identify nuclear reprogramming factors 
that would convert somatic cells back into pluripotency. Two broad screening 
strategies using the expression of stem cell marker Oct4 as a molecular read out were 
employed. 
i) Expression screening of Xenopus egg cDNA library: Xenopus eggs are totipotent 
as they have the capacity to give rise to whole organism. Xenopus egg cDNA libraries 
were screened by overexpression in various cell lines to isolate the genes that would 
upregulate the Oct4 expression. 
 ii) Chemical Genomics screen: A library of about 3000 small molecules available at 
the DKFZ-EMBL chemical genomics core facility was screened in a HEK293 stable 
cell line that harbours a luciferase reporter under the control of the Oct4 promoter and 
primary fibroblasts obtained from the mouse harbouring a GFP reporter under the 
control of the Oct4 promoter. 
I could not isolate any gene or small molecule that could specifically upregulate the 
Oct4 expression by the above mentioned screens. 
The second objective of this thesis concerns epigenetic changes during cellular 
differentiation. Several reports have indicated that DNA demethylation accompanies 
cellular differentiation. As a model case when C2C12 myoblasts were induced to 
differentiate into myotubes, the promoter of the muscle specific transcription factor 
Myogenin gene is demethylated and thereby facilitating its expression. Our group 
recently showed that Gadd45alpha mediates active DNA demethylation by a 
nucleotide excision repair mechanism. I tested if Gadd45 may mediate the 
demethylation observed during the C2C12 differentiation by knocking down the 
different isoforms of Gadd45. Gadd45beta knockdown blocked the Myogenin 
promoter demethylation as analysed by MS-PCR and COBRA assays. Moreover, the 
Myogenin expression was significantly reduced. In conclusion, Gadd45 is indeed 
required to relieve gene silencing during the differentiation of myoblasts into 
myotubes. 
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1.2 Zusammenfassung 
Das grundlegende Ziel dieser Arbeit war die Identifizierung von nukleären, 
reprogrammierenden Faktoren mit der Fähigkeit, somatische Zellen in pluripotente 
Zellen zu konvertieren. Hierfür wurden zwei umfassende Strategien angewandt, in denen 
die Expression des Stammzellmarkers Oct4 als molekularer Readout verwendet wurde. 
i) Expressionsanalysen unter Verwendung von Xenopus cDNA Bibiliotheken: 
Xenopus Eier sind totipotent, d.h. sie können Ausgangspunkt für einen kompletten 
Organismus sein. Eine cDNA Bibiliothek aus Xenopus Eiern wurde in verschiedenen 
Zelllinien überexprimiert, um Gene zu isolieren, die Oct4 Expression induzieren.  
ii) Chemische genomweite Analysen: Eine Bibliothek von 3000 kleinen chemischen 
Verbindungen der „DKFZ-EMBL chemical genomics core facility“ wurde für die 
Analyse in einer HEK293 stabilen Zelllinie verwendet, die ein Luziferase 
Reporterplasmid unter der Kontrolle des Oct4 Promotors trägt. Die Bibiolothek wurde 
ebenfalls in primären Fibroblasten einer transgenen Maus getestet, die einen GFP 
Reporter unter der Kontrolle des Oct4 Promotors tragen.  
Ich konnte in den durchgeführten Screens kein Gen oder Molekül isolieren, welches 
spezifisch die Oct4 Expression hochreguliert.  
Die zweite Fragestellung dieser Arbeit befasst sich mit epigenetischen Veränderungen 
während der zellulären Differenzierung. Mehrere Untersuchungen belegen, dass 
Differenzierung mit DNA Demethylierung einhergeht. So wird zum Beispiel während der 
Differenzierung von C2C12 Myoblasten zu Myotuben der Promotor eines Muskel 
spezifischen Transkriptionsfaktors Myogenin demethyliert und somit dessen 
Transkription induziert. Kürzlich wurde in unserer Arbeitsgruppe gezeigt, dass 
Gadd45alpha aktive DNA Demethylierung unter Einbeziehung von Nukleotid-
Entfernungsreparatur vermittelt. Ich habe getestet, ob Gadd45 ebenfalls ein Schlüsselrolle 
bei der Demethylierung  während der C2C12 Differenzierung  spielt, indem ich die 
Expression verschiedener Gadd45 Isoformen dezimiert habe. MS-PCR und COBRA 
Analysen zeigen, dass Gadd45beta Knockdown die Demethylierung des Myogenin 
Promotors blockiert. Darüberhinaus war die Myogenin Expression signifikant reduziert. 
Folglich ist Gadd45 in der Tat notwendig, Gen-Stilllegung während der Differenzierung 
von Myoblasten zu Myotuben aufzuheben. 
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2 Introduction 
We begin our life from fertilization of an egg by a sperm. The resulting zygote has the 
capacity to develop into a complete organism and hence is referred as the totipotent 
stem cell. As we grow from the zygote into a complete organism following a strict 
developmental program, most cells, except the gametes, lose this totipotency. Is it 
possible to reverse this program so that somatic cells re-acquire some stem cell 
characteristics? Any such generated stem cells could be differentiated into tissues and 
organs for use in cell replacement therapies. In order to transform this wishful 
thinking into a medical reality we ought to discover the reagents to convert our 
somatic cells into a stem cell state. Above all it is important that we understand the 
factors that determine the stem cell state. Furthermore, in order to drive the stem cell 
into a tissue of our choice, we need to know about the epigenetic programs that 
underlie a differentiated state. These questions form the frame work of my PhD 
thesis. 
In the first part of this thesis, I have searched for the reprogramming factors to 
convert a somatic cell into a stem cell state. In the second part, I have attempted to 
understand the mechanisms behind the epigenetic changes accompanying cellular 
differentiation using muscle differentiation as a model. 
2.1 Biology of Stem cells 
2.1.1 Characteristic properties of stem cells 
Two hall-mark properties of a stem cell are: 
i) Self-renewal: This refers to the ability to go through numerous rounds of cell 
cycles while still maintaining the undifferentiated state. To retain self-renewal, a stem 
cell can undergo two types of cell division (Figure 1). If a stem cell divides to yield 
two identical daughter cells that remain undifferentiated, the stem cell is said to have 
undergone a symmetric division. If one of the daughter cell remains undifferentiated 
and the other commits to differentiation then the stem cell is said to have undergone 
asymmetric division.  
. 
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Figure 1: Stem cell renewal. A - stem cells; B - progenitor cell; C - 
differentiated cell; 1 - symmetric stem cell division; 2 - asymmetric 
stem cell division; 3 - progenitor division; 4 - terminal differentiation.  
Reproduced from (En.wikipedia.org/wiki/Adult_stem_cell). 
 
 
 
 
 
 
Asymmetric division results in a stem cell and a progenitor cell. The progenitor cell 
undergoes several rounds of proliferation before terminal differentiation.  
ii) Potency: Potency of a cell refers to its ability to differentiate into different cell 
types. Based on the potency, stem cells can be termed as  
Totipotent (Toti: all): A totipotent stem cell can give rise to all the cell types 
that make up the body plus all of the cell types that make up the extra-
embryonic tissues such as the placenta. For example, the zygote is totipotent 
as it has the capacity to give rise to a whole organism. 
Pluripotent (Pluri: several but not all): These cells are the descendants of 
totipotent stem cells. They have the ability to differentiate into cells derived 
from the three germ layers, but cannot differentiate into extra embryonic 
tissues such as the chorion, amnion and other components of the placenta. For 
example, inner cell mass of a blastocyst, embryonic stem cells and embryonic 
germ cells. 
Multipotent (Multi: many) A stem cell is considered to be multipotent if it 
has the ability to develop into more than one cell type of the body. Often they 
give rise to a closely related lineage of cells. For example, hematopoeitic stem 
cells differentiate into red blood cells, white blood cells and platelets. 
Unipotent (Uni: single) cells has the ability to produce one cell type. 
However these cells have the capacity to self renew which distinguishes them 
from a differentiated cell. For example, skin stem cells are considered 
unipotent as they always differentiate only into skin. 
 All the above definitions are from http://stemcells.nih.gov/ info/glossary.asp. 
This section is summarised in the Figure 2.  
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Figure 2: Potency of cells varies. 
Stem cells are characterised by the properties of 
self-renewal and unlimited potency. Based on the 
potency, a cell can be termed as toti-, pluri-, 
multi- or uni- potent. Reproduced from 
(www.thebiotechclub.org/industry/emerging/ 
stem_cells.php). 
 
 
 
 
 
 
2.1.2 Derivation of stem cells 
After fertilization, the mouse zygote undergoes about six cleavage divisions before 
implantation. At this stage, a hollow-sphere of cells termed as blastocyst is formed. A 
Blastocyst is made up of about 64 blastomeres and has two distinct cell populations: 
i) Outer trophoectoderm cells which have lost their totipotency. These cells are 
necessary for implantation and for formation of the placenta. ii) ICM which forms the 
embryo proper. ICM cells cannot give rise to extra-embryonic tissues and hence is 
termed pluripotent. After implantation, the ICM develops into epiblasts cells of the 
early egg cylinder which retain pluripotency. These cells then respond to the signals 
from the surrounding extra-embryonic tissues that direct differentiation and initiation 
of gastrulation. At the onset of gastrulation, the primordial germ cells (PGCs) are 
specified. At this stage, pluripotency is restricted to PGCs and thereafter to germ cells 
which arise from them.  
Totipotent zygote and early blastomeres of an embryo undergo cleavage divisions 
instead of a normal cell division making it difficult to derive and establish in vitro 
cultures from them (Surani et al., 2007). ICM and PGCs however undergo a normal 
cell division and they respond to external signals making it possible to use them as 
precursors for the establishment of pluripotent cell cultures in vitro. Embryonic Stem 
(ES) cells and Embryonic Germ (EG) cells were derived from ICM (Evans and 
Kaufman, 1981; Thomson and Marshall, 1998) and PGCs (Matsui et al., 1992; 
Resnick et al., 1992; Shamblott et al., 2001) respectively. ES cell cultures have been 
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established from mouse (mES) (Evans and Kaufman, 1981), humans (hES) (Thomson 
and Marshall, 1998) and other mammalian species like bovines (Hwang, 2005), 
primates (Thomson et al., 1995), rabbit (Fang et al., 2006; Graves and Moreadith, 
1993) etc.  
Under optimal conditions, mES and hES may be cultured indefinitely. They can be 
induced to undergo differentiation in vitro as well as in vivo by forming teratomas 
upon implantation into immunosuppressed mice. To summarise, ES cells are artefacts 
of their in vitro environment because in vivo pluripotency of ICM is retained very 
transiently before it differentiates into egg cylinder and subsequently into germ layers 
(Surani et al., 2007).  
2.2 Determinants of pluripotency  
One of the key questions in the stem cell field is to understand the precise mechanism 
underlying self-renewal and pluripotency of stem cells. In recent years great strides 
were made in understanding the biology of stem cells. In the following section, I 
summarise various signalling pathways, transcription factors and epigenetic 
modifications implicated in maintaining mouse and human stem cell pluripotency.  
2.2.1 Signal transduction pathways 
a) LIF-STAT3 pathway 
Mouse ES are routinely propagated by co-culturing on a monolayer of mitotically 
inactivated mouse embryonic fibroblast (MEF) feeder cells. MEFs provide the ES 
cell with Leukaemia Inhibitory Factor (LIF), a cytokine of IL-6 family. Indeed 
recombinant LIF can be used instead of MEF feeder cells highlighting the importance 
of LIF in maintaining mES cells (Smith, 1988; Williams et al., 1988). LIF signals via 
a heterodimeric receptor complex composed of a specific low-affinity LIFR beta 
receptor chain and gp130 chain. Cytokine induced dimerisation results in activation 
of janus-activated kinases (JAKs) and signal transducer and activation of 
transcription (STAT), particularly STAT3 as well as mitogen activated protein kinase 
(MAPK). However, MAPK is reported to promote differentiation (Burdon et al., 
1999) and STAT3 activation is sufficient to maintain the pluripotency negating the 
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influence of MAPK activation (Nichols et al., 1998). The LIF/STAT3 pathway 
activates the targets such as growth factor Lefty 1, transcriptional regulators like c-
Myc, Id1 and Id2 and groucho-like protein Aes1 (Sekkai et al., 2005). Unlike mES 
cells, hES can maintain pluripotency by LIF/STAT3 independent mechanisms 
(Humphrey, 2004). Nevertheless components of LIFR and gp130 are found in hES 
cells. Exogenous addition of human LIF upregulates STAT3 levels, however this 
alone is insufficient to maintain hES pluripotency in vitro (Daheron et al., 2004). 
b) basic FGF pathway 
Usually human ES cells are cultured in the presence of basic fibroblast growth factor 
(bFGF) on a fibroblast feeder cells or in a fibroblast conditioned medium (Amit et al., 
2000; Xu et al., 2001). Although, bFGF is crucial for hES cell pluripotency, its exact 
mechanism of action is yet to be elucidated (Na Liu, 2007). 
The PI3K pathway, Wnt signalling and TGFβ signalling pathways are also implicated 
in maintaining the pluripotency of embryonic stem cells (Boiani et al., 2002; Rao, 
2004). 
2.2.2 Transcription factors 
a) Oct4 
Oct4, also known as Oct3 and encoded by Pou5f1, is a Pit-Oct-Unc (POU) domain-
containing transcription factor that binds to an octamer sequence, ATGCAAAT (Herr 
and Cleary, 1995; Ryan and Rosenfeld, 1997). Oct4 was first identified as a binding 
activity present in the extracts of undifferentiated embryonic stem cells and 
embryonic carcinoma Cells (Lenardo et al., 1989; Okamoto, 1990; Schoeler et al., 
1989b) The presence of Oct4 in pluripotent ES and EC cells prompted the 
investigators to study its expression and role during early mouse embryonic 
development.  
Expression  
Expression of Oct4 follows a strict developmentally regulated pattern (Figure 3). In 
mouse embryos, maternal Oct4 transcripts are present and after 4-cell stage, zygotic 
Oct4 expression is activated in all the blastomeres until late morula. In the blastocysts 
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stage, Oct4 expression is restricted to ICM and is downregulated in the 
 
Figure 3: Oct4 expression during mouse development. 
Oct4 is present as maternal transcript. Zygotic expression is activated prior to the 8 cell stage. 
It is expressed during morula and in the blastocyst stage its expression is restricted to ICM 
and later, at day 4.5, to migrating cells of differentiating primitive endoderm. Following 
implantation, Oct4 expression is limited to primitive ectodermal cells. Expression in 
primordial cells is detectable at day 8.5 (not shown). Adapted from (Pesce et al., 1998). 
trophoectoderm. At implantation, Oct4 expression is maintained in the primitve 
ectoderm. At the end of gastrulation, Oct4 expression is significantly down regulated. 
Thereafter, Oct4 expression is restricted to PGCs, precursors of the germ cells 
(Palmieri et al., 1994; Rosner, 1990; Schoeler et al., 1989a; Yeom et al., 1996; Yeom 
et al., 1991) Oct4
-/-
 embryos die at the time of implantation due to a failure to form 
ICM. Of note, suppression of Oct4 function does not affect the maintenance of 
totipotent phenotype of blastomeres prior to the formation of the blastocyst stage.  
 The unique Oct4 expression in the mouse embryo has lead to the hypothesis of the 
totipotent cycle. According to this postulate, cells losing Oct4 during embryonic 
development differentiate into somatic lineages whereas cells maintaining Oct4 
expression retain totipotency (Yeom et al., 1996). More over, when ES or EC cells are 
induced to differentiate, Oct4 mRNA expression is downregulated (Lenardo et al., 
1989; Schoeler et al., 1989a). Thus Oct4 expression is associated with 
undifferentiated cells, in vivo as well as in cell culture. However studies suggesting 
that i) Oct4 is expressed in low levels in adult tissues (Takeda et al., 1992) and ii) 
neuronal differentiation of ES cells could still proceed with sustained Oct4 levels, 
questions the widely held initial notion that Oct4 expression is downregulated in 
differentiated cells (Shimozaki et al., 2003). 
It is interesting to note that in mES cells, absolute levels of Oct4 is tightly regulated 
and is maintained within narrow limits. Any deviation from this limit promotes 
differentiation: An increased Oct4 levels leads to ES differentiation into endoderm 
Introduction 
9 
and mesoderm whereas decreased Oct4 levels promote differentiation into 
trophoectoderm (Niwa et al., 2000).  
The Oct4 gene has been found only in mammalian species. The human Oct4 and 
mouse Oct4 are 92% identical at amino acid level. Moreover human Oct4 expression 
pattern resembles that of mouse ortholog (Abdel-Rahman et al., 1995; Takeda et al., 
1992). To date, it has been very difficult to identify closer homologs of Oct4 in lower 
vertebrates. Of the several POU domain transcription factors identified in non 
mammalian species, zebrafish Pou2 (Zpou2) and axolotl Oct4 homolog (Axoct4) have 
a considerably very high amino acid identity (63% and 73% respectively) with 
mammalian Oct4. Xoct-25, Xoct-60, Xoct-79 and Xoct91 are identified as Xenopus 
POU classV homologs of mammalian Oct4. They have about 53-63% amino acid 
identity with mammalian Oct4 (Rosemary F. Bachvarova, 2004). During
 
Xenopus 
embryogenesis, these proteins act as suppressors of commitment during germ layer 
specification and thereby maintain multipotency. Moreover, Axoct4, Xoct-25, Xoct-60 
and Xoct-91 have the ability to maintain mouse ES cells in the absence of Oct4 
(Morrison and Brickman, 2006).  
Regulation 
The coding region of the mouse Oct4 gene consists of five exons and its regulatory 
region includes a TATA less promoter which is located within 250bp of transcription 
initiation site. The enhancer regions, Proximal Enhancer (PE) and Distal Enhancer 
(DE) are located approximately 1.2kb and 2kb upstream respectively (Figure 4). Even 
after nearly two decades since discovery, the transcriptional regulation of the Oct4 
expression is not yet completely understood. Transgenic analysis of the Oct4 
expression was carried out using a LacZ reporter gene linked to various regions of the 
Oct4 promoter sequences. An 18kb genomic fragment (GoF-18) was found to mimic 
the endogenous Oct4 expression. Deletion analysis concluded that Oct4 expression is 
regulated by three cis acting elements – the promoter, PE and DE (Okazawa et al., 
1991; Yeom et al., 1996; Yeom et al., 1991). 
The Oct4 proximal promoter consists of a GC box to which Sp1 transcription factor 
proteins can bind and three repeated half sites of the consensus hormone response 
element (HRE). HRE resembles a canonical retinoic acid response element (RARE) 
Introduction 
10 
to which receptors belonging to the steroid thyroid hormone receptor family including 
Retinoic Acid (RAR) and retinoid X receptors (RXR) bind. Overlapping this region is 
a putative binding site for ELP, a nuclear orphan receptor (Ben-Shushan et al., 1995; 
Okazawa et al., 1991; Schoorlemmer et al., 1994). Along with Oct4, other genes 
implicated in early embryonic development like E-Cadherin, HCGβ have a TATA less 
promoter. Sp1 transcription factor mediates the expression of these TATA less genes 
in the undifferentiated cells and early mouse embryos (Nothias et al., 1995; Ovitt and 
Schoeler, 1998). 
 
Figure 4. Genomic structure of the Oct4 gene. 
The diagram represents ~24kb of the genomic region surrounding the Oct4 gene. The gene is 
divided into five exons, depicted as black boxes. The identified upstream regulatory regions 
include the promoter, Proximal Enhancer and Distal Enhancer and are indicated by brackets 
whose length is proportional to that of the region. HRE = hormone responsive element; GC 
box is recognized by the Sp1 family of transcription factors Adapted from (Ovitt and 
Schoeler, 1998). 
Proximal Enhancer (PE) is a stage specific enhancer. In the developing embryo, its 
activity is limited to the primitive ectoderm. In contrast to its low activity in 
undifferentiated cells of the preimplantation embryos and ES cells, the PE is highly 
active in P19 EC cells. The PE has a cis-acting element which responds to retinoic 
acid (RA) mediated down-regulation of Oct4 expression, although no RA receptor 
binding site is present. This element can be subdivided into two sites (1A and 1B) and 
both the sites bind factors in vitro. However only site 1A is occupied in vivo in ES 
and EC cells (Okazawa et al., 1991; Ovitt and Schoeler, 1998; Yeom et al., 1996). 
Distal Enhancer (DE) is active in undifferentiated cells of the preimplantation embryo 
and is also responsible for the Oct4 expression in PGCs later in the development. The 
DE is crucial for the Oct4 expression in ES cells and is sufficient to enhance the LacZ 
reporter expression driven by a TK minimal promoter. The DE has a site 2A, that is 
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similar to, but present in opposite orientation to that of site 1A of the PE. In vivo, 
genomic foot printing experiments has demonstrated that this site is occupied by 
transcription factors in undifferentiated cells. However in the cells induced to 
differentiate with RA treatment, this site was observed to be unoccupied (Ovitt and 
Schoeler, 1998; Yeom et al., 1996). 
To sum up, the expression of Oct4 is temporally regulated such that the DE is active 
in ICM whereas the PE drives the expression in the primitive ectoderm and EC cells 
derived from it. The switch from DE to PE activity occurs around implantation. 
Following down regulation of Oct4 during gastrulation, DE regains activity in the 
PGCs. The selective activation of DE in the pluri/totipotent cells indicates that there 
are specific DNA-binding factors that may define the undifferentiated state. But these 
factors are not yet discovered. The aim of the thesis is to identify such upregulators of 
Oct4 which may be crucial in specifying pluripotency.  
Down stream targets and Function: 
Oct4 functions as a transcriptional activator of genes necessary for undifferentiated 
state of stem cells or as a suppressor of genes that are associated with the 
differentiated state. Target genes like Rex1, Osteopontin (OPN), and Fgf4 are 
associated with pluripotency and are subjected to a positive regulation by the Oct4 
transcription factor whereas expression of target genes like the alpha and beta 
subunits of human chrorionic gonadotropin, caudal-type homeobox transcription 
factor2 (Cdx2) expression are suppressed. Cdx2 triggers a pluripotent cell to 
differentiate into trophoectoderm. Oct4 prevents this by blocking the expression as 
well as the activity of Cdx2. Moreover, Cdx2 overexpression results in the 
downregulation of the Oct4 indicating these two proteins may constitute a negative 
feedback loop (Niwa et al., 2005). 
b) Sox2 
Sox2 is one of the key regulators of pluripotency. It is a member of the HMG-domain 
DNA-binding-protein family that is implicated in the regulation of transcription and 
chromatin architecture (Pevny and Lovell-Badge, 1997). The Oct4 and Sox2 proteins 
bind to the regulatory elements of the Fgf4 gene that encodes a stem cell specific 
growth factor and synergistically activates Fgf4 transcription (Yuan et al., 1995). 
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Interestingly regulatory regions of the Sox2 and the Oct4 gene have a Sox-Oct 
element to which Oct4/Sox2 complex binds and synergistically activate Sox2 and 
Oct4 expression respectively (Okumura-Nakanishi et al., 2004; Tomioka, 2002).
 
Sox2 
null embryos die immediately after implantation (Avilion, 2003). Knockdown of 
Sox2 in ES cells induces its differentiation into multiple lineages highlighting the 
importance of Sox2 in the maintenance of pluripotency (Ivanova, 2006).  
c) Nanog 
For nearly a decade, Oct4 was considered as the sole master regulator of pluripotency. 
The discovery of Nanog independently by the Yamanaka and Austin Smith groups 
(Chambers, 2003; Mitsui et al., 2003) has challenged this notion. Nanog may play an 
equally important role in specifying cellular pluripotency. Nanog is a homeobox 
containing transcription factor with an essential role in maintaining the pluripotent 
cells of the inner cell mass and ES cells. It is expressed in the pluripotent cells and is 
downregulated in differentiated cells. However using RT-PCR, Nanog transcripts are 
seen in adult cells (Hart et al., 2004). Overexpression of the Nanog in mES cells 
confers a LIF independent ability for self renewal and pluripotency. They are 
resistant, but not completely refractory, to the spontaneous differentiation that occurs 
after LIF withdrawal or by chemical induction after treatment with 3-
methoxybenzamide or all-trans RA. Nanog
-/-
 embryos do not develop beyond 
blastocyst stage due to failure to form an epiblast. Nanog
-/- 
ES cells, derived from 
these blastocysts, differentiate into parietal endoderm like cells. In contrast to Oct4
 -/-
 
ES cells, differentiation into trophoectoderm was not seen (Mitsui et al., 2003). Taken 
together, these data suggests that Nanog is critical for maintaining pluripotency of 
ICM at a stage after the initial requirement of Oct4. Overexpression of the Nanog 
promotes maintenance of pluripotent hES cells in feeder free conditions (Darr et al., 
2006). Like mES cells, hES also differentiate to extra-embryonic endoderm upon 
Nanog ablation (Hyslop et al., 2005). Nanog may function in a similar fashion like 
Oct4 by activating pluripotency specific genes like Rex1 and by repressing genes that 
promote differentiation like endodermal GATA-binding protein-6, Gata6 (Mitsui et 
al., 2003). Very little is known about regulation of the Nanog gene although Oct4, 
Sox2, P53 and FoxD3 have been implicated in this process (Kuroda et al., 2005; Lin, 
2005; Pan et al., 2006; Rodda et al., 2005).  
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d) Transcriptional network in pluripotency 
Oct4, Sox2 and Nanog are the main transcription factors involved in maintaining ES 
cell pluripotency. Oct4 and Sox2 interact to form an Oct4/Sox2 complex that 
positively regulates Oct4, Sox2 and Nanog expression. Oct4/Sox2/Nanog expression 
affects the expression of negative regulators of pluripotency like Cdx2, GCNF, Gata6, 
Coup-transcription factors. Cdx2 forms a reciprocal inhibitory loop with Oct4 which 
results in their mutually exclusive expression pattern. Oct4 is subjected to negative 
regulation by GCNF as well as Coup-transcription factors which are transcriptionally 
activated by Gata factors (Ben-Shushan et al., 1995; Fujikura et al., 2002). Moreover 
Nanog represses Gata6 expression thereby preventing the differentiation of ES cells 
into parietal endoderm. The transcriptional network is highlighted in the Figure 5. 
 
 
Figure 5: A transcription factor network to 
control ES cell pluripotency. 
Oct4, Sox2 and Nanog are the core regulatory 
transcription factors essential for ES cell 
pluripotency. Oct4 is negatively regulated by 
differentiation inducing Cdx2, Gcnf and Coup-tfs. 
Nanog suppresses the differentiation promoting 
Gata6 expression. Repression of Nanog by Gata6 
in ES cells is hypothesised. The figure is modified 
from (Niwa, 2007). 
 
 
 
 
 
 
 
 
 
2.2.3 Epigenetic mechanisms  
 Recently many novel epigenetic features of ES cells, which may help in delineating 
the molecular mechanism underlying cellular pluripotency, have been reported. Some 
of the key discoveries covering the ES cell - chromatin state, histone modifications 
and DNA methylation status would be highlighted in this chapter. 
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a) Chromatin features 
When compared to a somatic cell, ES cell chromatin has increased DNaseI 
hypersensitive sites, exhibits the features of acetylated histone (H4Ac) and 
methylated H3K4 (H3K4me3) (Meshorer, 2006), which are the hallmarks of 
transcriptionally active euchromatin. Due to the relaxed chromatin structure, the 
volume of ES cell nuclei is about double the volume of nuclei in differentiated cell 
(Faro-Trindade and Cook, 2006). Moreover in differentiated cells, inactive genes are 
positioned close to centromeric heterochromatin whereas in ES cells no such spatial 
compartmentalisation of inactive genes is observed (Smale, 2003). One unique 
feature of ES cells is the presence of so called bivalent domains in which chromatin 
elements that mark active state and those that mark inactive state coexist (Azuara, 
2006; Bernstein, 2006). 
Bivalent domains and Polycomb group of proteins: 
Histone modifications are associated with different chromatin states. Histone H3 
modifications like methylation of lysine 9 (H3K9me) or lysine 27 (H3K27me) are 
usually associated with inactive chromatin state as they recruit specific repressive 
proteins like HP1 and PRC1. Histone modifications like di and trimethylation of 
lysine 4 of H3 (H3K4me), acetylation of H3 or H4 mark transcriptionally active 
chromatin. Thus transcriptionally active genes are marked by H3K4me whereas 
inactive genes are marked by H3K9me or H3K27me. Contrary to the expectation, the 
inactive chromatin region of an ES cell was observed to contain H3K4me (active) and 
H3K9me (inactive) marks juxtaposed. Such chromatin domains are termed bivalent 
domains. This indicated a new model for gene regulation in pluripotent cells in which 
tissue specific genes are primed for expression but held in check by an opposing 
histone modification. Upon differentiation, these bivalent domains are resolved 
leading to transcriptional activation of the tissue specific genes (Spivakov and Fisher, 
2007).  
H3K27 methylation is catalysed by polycomb group (PcG) proteins. This indicated 
that the PcG proteins may play a crucial role in regulating gene expression in the ES 
cells. To date, four different PcG protein complexes have been characterised. Of 
these, Polycomb repressor complex1 (PRC1) and Polycomb repressor complex2 
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(PRC2) play an important role in the ES cells. PRC2 which consists of Ezh2, Eed and 
Suz12 catalyse methylation of H3K27. PRC1 which is made up of Ring1A and 
Ring1B is then recruited to H3K27me region and may repress the transcription by an 
unknown mechanism. In the undifferentiated ES cells, many PcG target genes carry 
bivalent domains. Moreover, PcG target genes are inactive in pluripotent cells but 
become derepressed upon differentiation. In PcG ablated ES cells, inappropriate 
upregulation of many tissue-specific target genes was observed. These observations 
have led to the conclusion that the PcG proteins play an essential role in maintaining 
pluripotency by preventing the premature expression of the differentiated state 
(Azuara, 2006; Bernstein, 2006; Boyer, 2006). 
b) DNA methylation 
DNA methylation at CpG islands is one of the prominent epigenetic mechanisms in 
mammals (Jaenisch and Bird, 2003). ES cells show unique DNA methylation profiles 
when compared to other cells like trophoectoderm stem cells, embryonic germ cells 
(Hattori et al., 2004). Moreover, mammalian genome has numerous tissue-dependent 
and differentially methylated regions (T-DMRs). Generally DNA methylation of T-
DMRs in gene loci causes transcriptional repression whereas demethylation leads to 
transcriptional activation (Imamura et al., 2001). The promoter of Oct4 is 
hypermethylated in differentiated cells whereas it is hypomethylated in ES cells 
thereby permitting its expression in the latter (Hattori et al., 2004). Similarly the T-
DMR of the Nanog gene is hypomethylated in ES cells whereas it is heavily 
methylated NIH3T3 cells in which the Nanog gene is repressed (Hattori et al., 2004). 
DNA methylation is essential for proper cellular differentiation and hence normal 
development of the organism (Li, 2002). I will elaborate more on this aspect in the 
chapter 2.4 
Maintanence of stem cell properties involves several mechanisms. However, we do 
not yet know what minimal factors are essential to establish a definitive pluripotent 
state. The acid test for any such authoritative pluripotency inducing factor(s) , if 
discovered, is their ability to convert a somatic cell to a pluripotent cell. Although we 
are far away from such authoritative pluripotency inducing factors, we have made a 
great progress in our ability to turn back the developmental clock of a somatic cell to 
a pluripotent state. The following section elaborates more on this theme. 
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2.3 Nuclear reprogramming of somatic cells 
A differentiated cell like a neuron always remain as a neuron and never change, under 
normal circumstances, to say a liver cell. Because of such a remarkable stable state of 
a differentiated cell, its cellular fate is said to be ‘sealed’. However, developmental 
biologists have shown that it is possible to reverse the cellular fate of a differentiated 
cell back to a pluripotent or totipotent state. Such a fate reversal is termed as nuclear 
reprogramming. Strategies like nuclear transfer, cell fusion, the use of pluripotent cell 
extracts, the use of defined reagents like small molecules or specific cocktail of genes 
have been exploited to demonstrate nuclear reprogramming. I discuss such strategies 
in the following sections. 
2.3.1 Nuclear reprogramming by nuclear transfer 
The procedure by which live animals are produced asexually by transferring a 
somatic nucleus into enucleated eggs is referred to as somatic cell nuclear transfer or 
animal cloning. The first animal cloning experiments in metazoans were 
demonstrated by hatching tadpoles that were obtained by transfering an early blastula 
nuclei into an enucleated oocyte of the the frog Rana pipens (Briggs and King, 1952). 
The success of nuclear transfer experiments revised the widely held notion among the 
nineteenth century embryologists that a cell undergoes a stable change in its genetic 
constitution with development and differentiation (Di Berardino, 2001). Moreover 
these experiments have estabished the capacity of egg cytoplasm to reprogram a 
somatic cell nuclei to a pluripotent state (Byrne et al., 2003).  
Several years of ambhibian cloning experiments in Rana and Xenopus can be 
summarised as follows: i) Nuclei of early embryonic cells upon nuclear transfer 
yielded normal tadpoles, hence they are totipotent. ii) The success of nuclear transfer 
is inversely correlated with the age of the donor cell. Nucleus from early 
developmental stage cells can be succesfully reprogrammed than the late stage cells 
(Di Berardino et al., 2003). iii) Normal feeding stage larvae were obtained from a 
range of transplanting adult tissues like kidney, lung and skin. However they did not 
survive further. In no case was an adult animal obtained by nuclear
 
transplantation 
from the cell of an adult frog (Gurdon, 2006; Gurdon and Byrne, 2003).  
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Mammalian reproductive cloning was first demonstrated in the sheep Dolly 
(Campbell et al., 1996) and subsequently in cows (Cibelli et al., 1998), pigs (Onishi et 
al., 2000), cats (Shin et al., 2002), goats (Baguisi et al., 1999), mice (Wakayama et al., 
1998) etc. Moreover, mammalian clones have been obtained from the transfer of 
transgenic nuclei. For example, the sheep Polly was produced from a lamb cell that 
harbours human clotting factor IX (Wilmut, 1998).  
Mammalian cloning is extremely inefficient, with most of the clones dying soon after 
implantation. In most of the embryos that survived, developmental and physiological 
abnormalities including premature death has been observed. Since many of these 
abnormalities are not inherited, it is thought that they arise due to an incomplete 
reprogramming of somatic nuclei in the egg (Gurdon and Byrne, 2003). Like 
amphibian cloning, the efficiency of mammalian cloning also depends on the 
differentiation status of the donor nuclei. For example cloning of mice from the nuclei 
of mouse embryonic blastomeres and mES cells are highly efficient than from the 
nuclei of adult cells like fibroblasts, cumulus etc (Cheong et al., 1993; Eggan et al., 
2001; Rideout et al., 2000; Wakayama and Yanagimachi, 1999). Despite these 
progress with mammalian cloning, until now, no ES cell line has been established by 
the nuclear transfer of human cells (Hochedlinger and Jaenisch, 2006). Moreover this 
line of research is severely affected because of social and ethical concerns over 
oocytes donation (Wakayama and Yanagimachi, 1999). This has lead scientists to 
divert their attention towards developing alternative approaches for reprogramming 
human cells which avoid the use of human oocytes. Before discussing these 
alternative options, I would like to elaborate on what happens to a somatic nuclei 
transferred into egg cytoplam. 
Transplanted nucleus undergoes morphological changes including nucleoli 
breakdown (Gonda et al., 2003), marked enlargement and chromatin dispersal 
(Gurdon, 2006). When transferred into an egg cytoplasm, DNA replication of the 
somatic nucleus is rapidly induced before any commencement of transcription. 
However DNA transcription rapidly starts if the nucleus is transferred into an 
Xenopus oocyte (Gurdon and Byrne, 2003). The transcriptional programme of the 
transferred somatic nucleus is affected by several proteins which are dynamically 
exchanged between the egg microenvironment and the nucleus. First, somatic linker 
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histones are replaced with embryonic types from the recipient cytoplasm (Dimitrov 
and Wolffe, 1996). However the core-histones are not exchanged and changes in their 
post-translational modifications in the egg cytoplasm is not clearly understood (Wade 
and Kikyo, 2002). Second, proteins of the basal transcriptional machinery are 
exchanged. Upon incubation with Xenopus cytoplasmic extracts, proteins like TBP, 
TFIIB and TFIIF are eliminated from the nucleus into the egg cytoplasm. This loss is 
mediated by nucleosomal ATPase ISWI protein present in the egg cytoplasm (Kikyo 
et al., 2000). Third, methylation pattern of the somatic nucleus undergo a change. 
When a human thymocyte is transferred into Xenopus oocyte, the promoter of the 
Oct4 gene undergoes active demethylation before its transcription (Byrne et al., 
2003). This active demethylation could be mediated by Gadd45alpha (Barreto et al., 
2007). 
2.3.2 Nuclear reprogramming by cell fusion 
Historically cell-cell fusions have been used to demonstrate the phenotypic 
dominance of one fusion partner over the other (Baron and Maniatis, 1986; Blau and 
Blakely, 1999). To date, various cell fusion combinations have been tried including 
the fusion of somatic cells with pluripotent cell types of ES (Tada et al., 2001), EG 
(Tada et al., 1997) and EC origin (Andrews and Goodfellow, 1980). In the resulting 
hybrids the phenotype of the pluripotent cell is dominant over that of the somatic 
counterpart (Flasza et al., 2003). The following evidences substantiate this:   
(i) X-chromosome inactivation is essential to equalize the X-linked gene dosage 
between XX females and XY males. An inactive X chromosome of female PGCs is 
reactivated soon after they enter into the developing gonads in the mouse. This X 
chromosome reactivation is considered to be one aspect of the overall genomic 
reprogramming events that is linked to toti/pluripotency. Similarly an inactive X 
chromosome of the thymocyte was reactivated in the male ES cell x female 
thymocytes hybrids (Tada et al., 2001). X chromose reactivation was also seen in EC 
x thymocytes fusion (Takagi et al., 1983). However, the EC hybrids did not produce 
chimeras upon transplantation into blastocysts showing that the thymocyte had not 
undergone a complete nuclear reprogramming. 
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(ii) In Oct4-GFP transgenic mice, GFP is expressed in pluripotent cells but not in 
thymocytes. Fusion of such thymocytes with ES (non-GFP background) cells 
reactivated the GFP expression in hybrids (Tada et al., 2001).  
(iii) Fusion between murine P19 and human T-lymphoma cell line resulted in inter-
species hybrids in which expression of the human specific Oct4 and Sox2 were 
upregulated whereas a lymphocyte marker CD45 was downregulated (Flasza et al., 
2003). 
(iv) Recently it was shown that human fibroblasts could be reprogrammed by fusion 
with human ES cells (Cowan et al., 2005). A fibroblast cell that harbours a 
pluripotency reporter, Rex-1 GFP  was fused with GFP negative human ES cells. 
Although fibroblasts do not show any GFP expression, the hybrid cells express Rex-1 
GFP and exhibit other pluripotency features like expression of the Oct4 transcription 
factor, alkaline phosphatase activity, telomerase activity and surface antigens like 
SSEA4, TRA 1-61, TRA 1-81. Moreover when the expression profiles of fibroblasts 
and hybrids were compared, somatic gene expression was downregulated in the 
hybrids. 
These results raise a number of questions: It is not clear whether the somatic donor 
nucleus has been fully reprogrammed and has regained the potential to sustain 
pluripotency in the absence of ES (or EC) cell genome. Since these are intraspecies 
fusion studies it is impossible to analyse if the endogenous Oct4 gene expression is 
also induced along with the transgene reporter expression in the hybrids. Above all, 
one substantial technical barrier in using the tetraploid ES cell-somatic cell hybrids to 
generate patient specific stem cells for therapy is to remove the ES cell chromosomes 
after the somatic partner has undergone a complete nuclear reprogramming (Cowan et 
al., 2005). 
 A recent report (Matsumura et al., 2007) has addressed many of the above concerns. 
The authors have designed a universal chromosomal elimination casette (CEC) that 
has lox-P sites for the elimination of both the copies of chromosome 6 of a mouse ES 
cell that encodes the Nanog gene. An ES cell engineered with a CEC casette was 
fused with the fibroblasts to create a hybrid cell. Then cre mediated recombination led 
to the complete removal of chromosome 6 of the ES counterpart. In hybrids, the 
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Nanog gene expression was reactivated from the somatic counterpart. Pluripotency of 
cre-treated hybrid cells was also demonstrated by the formation of teratomas.  
 In regenerative medicine, major histocompatibility complex (MHC)-matched stem 
cells are eagerly awaited as a source for producing replacement tissues to minimise 
any immunological rejection. The majority of MHC class I and class II genes are 
clustered on human chromosome 6 and mouse chromosome 17. Selective elimination 
of ES cells-derived MHC gene–containing chromosomes from ES-somatic hybrid 
cells may provide a source of personal MHC-matched hybrid cells. The CEC 
approach can be used to generate MHC-personalized diploid ES cells by targeted 
elimination of ES cell chromosomes harboring the MHC genes and replacing both 
copies with somatic cell–derived MHC chromosomes using a special microcell-
mediated chromosome transfer technique (Tomizuka et al., 1997) (Figure 6).  
 
Figure 6: Scheme of generating MHC-matched stem cells.  
The proposed scheme involves cell-cell fusion and chromosome elimination cassette. 
Adapted from (Matsumura et al., 2007). MHC refers to Major histocompatibility complex 
and ESCs refers to ES cells. 
2.3.3 Nuclear reprogramming by cell extracts 
Conventionally, Cell extracts have been widely used to investigate various nuclear 
processes such as DNA replication, chromosome and nuclear envelope dynamics 
(Martins et al., 2000; Poccia and Collas, 1996). The newfound application of cell 
extracts is in nuclear reprogramming. The Collas group showed for the first time that 
upon permeabilisation and brief incubation with T-cell extracts and neuronal cell 
extracts, human kidney cells HEK293T cells could be reprogrammed to induce T-cell 
specific genes and neuronal genes respectively (Hakelien et al., 2002). The Niehrs 
group developed a protocol to reprogram human cells using Xenopus extracts to 
upregulate the expression of pluripotency genes like Oct4 and GCAP (Hansis et al., 
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2004). The usage of this reprogramming protocol was further extended to cells like 
human primary lymphocytes. In the reprogrammed lymphocytes, expression of the 
pluripotency markers increased. However the cells had a limited life span and did not 
express surface antigens characteristic of pluripotent cells indicating that 
reprogramming was incomplete. This study identified BRG1 (Khavari et al., 1993), a 
chromatin remodeling ATPase, as a necessary factor in nuclear reprogramming. To 
conclude, human cells were shown to be reprogrammed, although incompletely, by 
Xenopus extracts. In a conceptually related approach, pluripotent ES and EC extracts 
have been used to reprogram 293T cells (Taranger et al., 2005). On exposure of 293T 
cells to EC cell extracts: i) The promoters of pluripotent genes like Oct4, Nanog were 
demethylated. ii) Chromatin at the Oct4 and Nanog loci underwent drastic 
remodeling so as to support their transcription. iii) Oct4, Nanog expression was 
drastically upregulated, as analysed by RT-PCR and immunofluorescence, with a 
concomitant downregulation of differentiation specific markers. iv) The capability to
 
differentiate toward neurogenic, adipogenic, osteogenic, and
 
endothelial lineages 
were enhanced. 
To conclude, these studies have once again shown that cytoplasm of the pluripotent 
cells has the ability to reprogram a somatic cell. The major advantages with the 
extracts mediated reprogramming are i) They facilitate the identification of 
biochemical components involved in nuclear reprogramming and ii) Both the somatic 
cell and the reprogramming extract could be manipulated so as to obtain complete 
reprogramming. 
2.3.4 Nuclear reprogramming by defined 
reagents 
Several lines of evidences indicate that overexpression or loss of function of a single 
gene can facilitate dramatic fate changes in a somatic cell. For example, over 
expression of MyoD alone into fibroblasts is sufficient to induce muscle specific 
characters in them (Weintraub et al., 1989). In the nervous system, oligodentrocyte 
precursor cells could be reprogrammed into multipotential neural stem cells by 
sequential exposure to fetal calf serum and basic FGF (Baba et al., 2005). Ectopic 
expression of CCAAT/enhancer-binding protein (C/EBPα and C/EBPβ) into B cells is 
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sufficient to reprogram them into macrophages (Xie et al., 2004). Similarly loss of 
Pax5, a transcription factor necessary for B-cell development, endows the pro B-Cells 
with a broad developmental potential similar to that of the HSC itself (Nutt et al., 
1999). Ectopic activation of β-catenin destabilizes lineage fate decisions and confers 
some stem cell properties on committed lymphoid or myeloid progenitors (Baba et 
al., 2005). In C.elegans, mutations in the retinoblastoma pathway components results 
in a soma to germline transformation (Wang et al., 2005). These findings support the 
hypothesis that defined factors master regulating the reprogramming of a somatic cell 
into a pluripotent state may exist and, it is possible to find them by Gain-of-function 
strategies. This is as well the major question of this PhD thesis.  
Two different reports (Chen et al., 2004; Takahashi and Yamanaka, 2006), that have 
appeared during the course of this PhD thesis, contributes significantly towards 
delineating such defined factors. A chemical genomics screen was done to identify 
small molecules capable of lineage reversal (Chen et al., 2004).  
Figure7: Reprogramming by small molecules. 
 Reversine, a small molecule mediates the dedifferentiation of 
C2C12 mouse myoblasts to multipotent mesenchymal 
progenitor cells. These cells could then be differentiated into 
adipocytes or osteoblasts under appropriate differentiation 
conditions. This figure is reproduced from (Ding and Schultz, 
2004). 
 
 
 
This led to the discovery of myo-reversine, a 2, 6 disubstituted purine, that could 
dedifferentiate lineage-committed C2C12 muscle cells to become multipotent 
mesenchymal progenitor cells, which then can proliferate and redifferentiate into 
bone and fat cells (Figure 7). 
In a landmark paper (Takahashi and Yamanaka, 2006), the authors have 
reprogrammed a differentiated mouse embryonic fibroblasts into an ES state by 
overexpressing a combination of four genes- Oct4, Sox2, C-Myc and Klf4. None of 
the candidates tested individually could reprogram the fibroblasts. Interestingly 
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Nanog was dispensible. The reprogrammed cells resembled but were not identical to 
ES cells by microarray expression analysis. Furthermore, like ES cells, the 
reprogrammed cells formed embryoid bodies in culture and produced teratomas when 
injected into mice. 
 
Figure 8: Reprogramming by defined factors.  
Embryonic and adult mouse fibroblasts expressing a selectable marker (β-geo) driven by an 
ES cell-specific promoter (Fbx15) were transduced with retroviruses encoding Oct4, Sox2, C-
Myc and Klf4. These factors reprogram the fibroblasts into an induced pluripotent (iPS) cells 
and have many properties similar to an ES cell. The reprogrammed cells were scored by their 
beta galactosidase activity and G418 resistance. This Figure is modified from (Rodolfa and 
Eggan, 2006). 
The induced cells also differentiated to produce all three embryonic germ layers, 
confirming their pluripotency. However upon injection into blastocysts, the 
reprogrammed cells contributed to mouse chimeras only upto E13.5 and no live 
chimeric pup could be obtained. The Oct4 promoter was only partially demethylated. 
In summary, it appears that the cells were not fully reprogrammed. Moreover it is not 
yet known if these four factors are sufficient to reprogram human cells. Although 
practical application of this approach requires more work, this seminal paper has 
authoritatively illustrated that nuclear reprogramming by defined factors is a reality. 
To summarise this section, I have discussed the molecular determinants of 
pluripotency. One crucial parameter among them is the epigenetic status of a cell. 
Epigenetics is a broad term to describe the covalent modifications of DNA especially 
methylation and demethylation of its bases and histone modifications that bring about 
a change in the conformation of the chromatin so as to regulate the expression of a 
gene. Cells do not express all the genes present in their genome at a time. In fact, 
each cell type has its unique gene expression profile and hence its unique epigenetic 
signature. For example, epigenetic profile of a pluripotent cell is different from that of 
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a differentiated cell. The following chapter discusses epigenetic aspects focusing on 
DNA methylation during animal development and differentiation. 
2.4 Epigenetics and cell differentiation 
The course of development of organism from its pluripotent state to differentiated 
state involves changes in gene expression. Embryo specific genes are shut down and 
tissue specific genes are turned on. This change in gene expression profile depends on 
the methylation status of the promoter of the gene in question. Along with other 
standard bases, vertebrate genomes contain 5-methyl cytosine which is restricted to 
Cytosine followed by Guanosine (CpG) dinucleotide. In the genome of vertebrates, 
approximately 80% of all CpG-dinucleotides are subject to methylation. Exceptions 
to this rule are so-called “CpG-islands’’, regions of DNA with high density of CpGs 
(Antequera and Bird, 1993). CpG methylation is implicated in a variety of processes, 
including genome organisation and stability (Niwa et al., 2000), transposon silencing, 
X chromosome inactivation, genomic imprinting, tissue specific gene expression and 
disease conditions like cancer (Jaenisch and Bird, 2003). 
2.4.1 CpG methylation and gene silencing 
CpG methylation is usually inversely correlated with gene expression. For example, 
genes, when transfected into cells, are not expresssed if their promoters have been 
methylated in vitro (Razin and Cedar, 1991). Moreover, endogenous genes could be 
activated by treatment of cells with a DNA demethylating drug, Aza (Mayer et al., 
2000). Several models are available to explain the methylation mediated 
transcriptional silencing:  
i) DNA methylation in the cognate transcription factor binding site could prevent the 
transcription factor from binding to the DNA by steric hindrance (Watt and Molloy, 
1988). 
ii) Attempts to digest methylated and unmethylated regions in the genome using 
endonucleases such as DNaseI clearly demonstrate that the former are relatively 
refractory to digestion, indicating a closed chromatin structure (Tamame et al., 1988). 
When methylated and unmethylated variants of the Herpes simplex virus thymidine 
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kinase (TK) gene were introduced into rodent cells in order to monitor TK activity, a 
time dependent repression of methylated construct was observed (Buschhausen et al., 
1987; Graessmann and Graessmann, 1988). These observations indicate that the 
methylated construct assembles a repressive chromatin structure, in which basal-RNA 
polymerase II transcription machinery cannot access the promoter sequences, leading 
to transcriptional shutdown. Over the years, how such a repression is brought about 
has been understood. In short, CpG methylation sequence at the promoter region 
causes the binding of methylated CpG-binding proteins (MBPs) that are characterised 
by their methyl binding domains (MBD). These proteins, generally, then recruit 
Histone deacetylase complexes (HDAC) which removes the lysine acetylation of the 
core histones thereby shutting down the transcription (Baker and El-Osta, 2003).  
iii) The methylation of mammalian genomic DNA is catalyzed by DNA methyl 
transferases (DNMTs). In addition to this conventional role, DNMTs have been 
shown to biochemically interact with histone methyl transferases and histone 
deacetylases (Fuks et al., 2000) thereby forming a repressive chromatin structure. 
iv) In mammalian genome many CpGs are found in the intronic regions of a gene. In 
order to study the effect of methylation of these intragenic CpGs on transcription, a 
patch methylated GFP reporter (promoter is unmethylated whereas reporter is 
methylated) was targeted to a specific genomic loci. This study found that the 
methylated reporter expression was low when compared to unmethylated controls. 
The methylated region exclusively adopted a closed chromatin structure that depleted 
Polymerase II occupancy (Lorincz et al., 2004). 
2.4.2 Mediators of DNA methylation and 
demethylation 
The DNA methyl transferases (DNMTs) can be divided into de novo and maintenance 
methyl transferases (Fang et al., 2006). De novo DNMTs like Dnmt3a, Dnmt3b 
catalyses the methylation of Cytosine to 5-methylCytosine post-replicatively in an 
unmethylated DNA template. Maintenance DNMT, Dnmt1 essentially copies the pre-
existing methylation pattern by preferentially mediating cytosine methylation of 
hemimethylated DNA strand during replication. Apart from these, Dnmt2 and 
Dnmt3L have been described. Dnmt2 has a very weak methyl transferase activity in 
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vitro and Dnmt3L has no catalytic activity by itself but physically interacts with 
Dnmt3a and Dnmt3b to regulate their function (Klose and Bird, 2006). 
In contrast to the rich knowledge about the enzymes mediating DNA methylation, the 
key players of DNA demethylation are not yet fully described. The DNA 
demethylation could be global or local (site specific) in scale. For example, a wave of 
global DNA demethylation is observed during gametogenesis in mammals. Site 
specific demethylation is observed during tissue specific gene expression (Kress et 
al., 2001). For example, the promoter of the muscle specific transcription factor 
Myogenin is methylated in myoblasts. Upon differentiation into myocytes, the 
Myogenin promoter is demethylated concomitant with its expression (Lucarelli et al., 
2001). The DNA demethylation could be occur by passive or active process, or a 
combination of both (Jaenisch and Bird, 2003). Passive DNA demethylation occurs 
by inhibition or lack of maintenance DNA methyltransferases throughout cycles of 
replication, whereas active DNA demethylation, being replication independent, 
requires specific enzymatic reactions. Such active DNA demethylation is observed in 
vivo during germline establishment and embryogenesis (see below). Despite several 
attempts, until now, no DNA demethylase enzyme has been isolated in mammals. In 
order to account for the observed active DNA demethylation, three mechanisms have 
been proposed (Figure 9):  
 
Figure 9: Possible mechanisms for DNA demethylation.  
Three methods via a) Direct excision of methyl group b) 
Base excision and c) Nucleotide excision.  
This Figure is obtained from (Kress et al., 2001). 
 
 
 
 
i) Direct removal of the methyl group: This involves a thermodynamically 
unfavorable breakage of the carbon–carbon bond that links the pyrimidine to its 
methyl group. The human MBD2 was reported to demethylate DNA by this 
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mechanism (Bhattacharya, 2004; Ramchandani et al., 1999). This claim was 
contested and could not be reproduced in other laboratories (Kress et al., 2001). 
ii) The methylated base could be removed by base excision repair mechanism: For 
example, In Arabidopsis, DNA demethylation is mediated by DEMETER, ROS1 
proteins. These are bifunctional enzyme with DNA glycosylase and DNA lyase 
activity. The DNA glycosylase initiates the base excision repair process by 
specifically excising 5-methylcytosine through cleavage of the N-glycosylic bond. 
Lyase activity of the enzyme subsequently nicks the DNA. Later other components of 
the base excision repair mechanism are recruited – briefly an AP endonuclease 
generates a 3-hydroxyl group to which a DNA repair polymerase adds an 
unmethylated cytosine. DNA ligase completes the repair process by sealing the nick 
(Gehring et al., 2006; Gong, 2006). DNA glycosylases that mediate active DNA 
demethylation have also been isolated from chicken extracts (Jost, 1993).  
 iii) The nucleotide containing the methylated base could be removed by nucleotide 
excision repair mechanism. Recently in this group, Gadd45alpha was discovered to 
mediate an activate DNA demethylation (Barreto et al., 2007). Gadd45alpha was 
discovered by a simple but elegant screening of Xenopus gastrula cDNA library for 
the genes that active a methylation suppressed reporter expression in HEK293T cells. 
Overexpression of xGadd45alpha resulted in a global as well as local demethylation 
as evident from the observed demethylation of repetitive elements and that of Oct4 
promoter respectively. Several lines of evidences presented in the paper suggest that 
Gadd45alpha mediates active rather than a passive demethylation. 
i) Gadd45 mediated the DNA demethylation of the promoter of the injected Oct4 
gene in Xenopus oocytes in which no DNA replication takes place ruling out passive 
mechanism. 
ii) Gadd45 mediated the DNA demethylation of plasmid DNA in cell culture. Since 
plasmid DNA as well does not replicate, the observed demethylation should be active. 
iii) Gadd45 overexpression in serum starved, and hence replication arrested, cells 
could still induce global DNA demethylation unlike Aza that acts only on 
proliferating cells.  
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Gadd45alpha was shown to be recruited specifically to the demethylation site and 
mediated the observed demethylation by nucleotide excision repair mechanism. 
Gadd45alpha knockdown lead to DNA hypermethylation.Three isoforms of Gadd45, 
Gadd45alpha / beta / gamma which constitute the Gadd45 family of proteins, were 
earlier implicated in cell cycle regulation, cellular senescence and apoptosis. It is not 
clear if Gadd45beta and Gadd45gamma isoforms, as well, are implicated in 
demethylation. How does Gadd45 is targeted to the methylated loci is yet to be 
addressed.  
2.4.3 DNA methylation and demethylation in 
development 
A surge of methylation and demethylation of the genome is observed during 
mammalian embryogenesis as well as germline development. 
Germline reprogramming: As soon as mouse primordial germ cells enter the genetic 
ridge, their genomes undergo a wave of active demethylation (Surani et al., 2007). 
However the methylation patterns are re-established by de novo methylation during 
early differentiation of the germ cells in the gonads. Remethylation of the male germ 
line seems to occur from E16 onwards whereas that of the female germline takes 
place only after birth during the growth of oocytes. By this cycle of erasure and 
regaining of methylation marks, gametes acquire sex-specific imprints. Moreover 
carry over of any faulty methylation imprints from adult cells into the germline is 
minimised (Allegrucci et al., 2005). 
Reprogramming in early embryogenesis: DNA of both oocyte and sperm is heavily 
methylated. On fertilisation, the paternal genome undergoes genome-wide loss of 
methylation. Since this occurs in the absence of any DNA replication, it is referred to 
as active demethylation. However the maternal genome undergoes replication 
dependent passive demethylation. Such a genome-wide demethylation is significant 
as it erases all the epigenetic information
 
originating in the highly differentiated 
gametes. This is essential for the establishment of a pluripotent state before specific
 
cell lineages are determined. After implantation,
 
a de novo methylation activity 
produces in the gastrula a methylation
 
pattern characteristic of the adult animal. By 
these mechanisms, cells erase all the gamete specific epigenetic marks and acquire 
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embryo specific methylation marks (Reik et al., 2001). During the subsequent
 
development, tissue-specific genes undergo specific demethylation
 
events required for 
their transcriptional activation (Razin and Shemer, 1995). Several reports of tissue-
specific demethylation of genes along with cellular differentiation have emerged. For 
example, a global demethylation is observed in differentiating murine carcinoma F9 
cells and in mouse erythroleukemia (Adams et al., 1990; Bestor et al., 1984); 
demethylation of specific genes like CD8alpha and CD8beta during thymocytes 
differentiation (Fitzpatrick and Wilson, 2003), heavy and light chains of Ig 
demethylation during B cell development (Weiss and Cedar, 1997), demethylation of  
IL2, IL4 (Fitzpatrick and Wilson, 2003), Endothelin (Vallender and Lahn, 2006) 
correlating with their expression have been reported.  
Several observations have underscored the importance of DNA demethylation during 
muscle differentiation. 10T1/2 embryonic fibroblasts could be converted to muscles 
upon treatment with methyltransferase inhibitor, Aza. This study had lead to the 
discovery of the muscle specific transcription factor MyoD (Davis et al., 1987). 
Moreover, the distal control element of the MyoD promoter undergoes demethylation 
during somitogenesis in mice (Brunk et al., 1996) and is necessary for the MyoD 
expression. 
A genome-wide demethylation has been observed in the mouse myoblasts induced to 
differentiate, which attains a maximum 2 days after the onset of differentiation (Jost 
et al., 2001). This global demethylation seems to be a two-step process that starts with 
the generation of a hemimethylated site, which in turn becomes the substrate of 5-
methylcytosine DNA glycosylase. After 2 days, however, there is a partial 
remethylation of the genome, suggesting a broader role for this epigenetic 
modification during myogenesis (Jost et al., 2001). DNA remethylation is restored by 
the aid of a muscle specific Dnmt-1 (Aguirre-Arteta et al., 2000). This shorter isoform 
of the maintenance methyltransferase is not detected in myoblasts, but its expression 
is upregulated in differentiating myotubes. The correlation between muscle 
differentiation and DNA methylation is further underscored by the finding that the 
muscle specific transcription factor Myogenin promoter becomes demethylated at the 
onset of differentiation of the C2C12 muscle myoblasts (Lucarelli et al., 2001). 
Although demethylation was observed in several cases detailed above, a specific 
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demethylating factor was not described. It is possible that Gadd45 genes may mediate 
the observed demethylation.  
2.5 Experimental aims and strategies  
The primary aim of the thesis was to screen for the reprogramming factors that may 
convert a somatic cell into a pluripotent cell. I used upregulation of Oct4, an 
embryonic stem cell marker and one of the key determinants of pluripotency as the 
molecular readout.  
Basically two broad strategies were employed: i) Expression screening of Xenopus 
egg cDNA library; ii) Chemical Genomics screen. 
i) Expression screening of Xenopus egg cDNA library: Xenopus eggs are totipotent 
as they have the capacity to give rise to whole organism. So Xenopus eggs should 
express factors that maintain totipotency. Our own previous results shows that when 
differentiated HEK293T cells were incubated with Xenopus egg extracts, the cells 
aggregate into spheroids and Oct4 expression is upregulated in these spheroids 
(Hansis et al., 2004). Hence I decided to screen Xenopus egg cDNA libraries for the 
factors that upregulate Oct4 expression. Various screens were performed as will be 
described in detail. 
ii) Chemical Genomics screen: A library of about 3000 small compounds available 
at DKFZ-EMBL chemical genomics core facility was used to screen a HEK293 stable 
cell line that harbours a luciferase reporter under the control of the Oct4 promoter and 
primary fibroblasts obtained from a mouse harbouring a GFP reporter under the 
control of the Oct4 promoter. 
As all these screens failed to identify the desired products, as a second objective of 
this thesis I investigated the epigenetic changes during muscle differentiation. When 
C2C12 myoblasts were induced to differentiate into myotubes, the promoter of a 
muscle specific transcription factor Myogenin gene is demethylated and thereby 
promotes its expression. However the demethylating factor was not known. Recently 
Gadd45alpha was discovered in this group to mediate active DNA demethylation by 
nucleotide excision repair mechanism. It is possible that Gadd45 may mediate the 
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demethylation observed during the C2C12 differentiation. I addressed this question 
by knocking down the different isoforms of Gadd45 and to check the consequence on 
the differentiation of C2C12 myoblasts into myotubes.  
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3 Results 
The results section is divided into two main parts. Part I deals with the screening for 
reprogramming factors and Part II is a summary of investigation of Gadd45 as a 
mediator of active DNA demethylation in HCT116 Dnmt1
-/-
 cells and C2C12 cells. 
Part I: Screening for reprogramming factors 
The main objective of this work was to screen for the nuclear reprogramming factors 
using Oct4 as a molecular marker. Towards this end, the following approaches were 
used: i) Expression screening of Xenopus cDNA libraries: A Xenopus tropicalis 
oocytes cDNA library and a library of cDNA prepared from the embryo stages10-30 
were screened (Chapter 3.1) and ii) Chemical genomics approach in which a library 
of small molecules was screened (Chapter 3.2). 
3.1 Expression screening of Xenopus tropicalis 
cDNA libraries 
Xenopus eggs are totipotent as they have the capacity to give rise to whole organism. 
So Xenopus eggs should express factors that are essential for totipotency. Our own 
previous results shows that when differentiated HEK293T cells were incubated with 
Xenopus egg extracts, the cells aggregate into spheroids and the Oct4 expression is 
upregulated in these spheroids (Hansis et al., 2004). Hence I decided to screen the 
Xenopus tropicalis cDNA libraries for the factors that upregulate the Oct4 expression 
using two different types of readouts: the upregulation of GFP reporters that are 
controlled by regulatory sequences of the Oct4 gene or upregulation of the 
endogenous Oct4. 
GFP as readout 
By using the upregulation of Oct4 GFP reporters as readout, the following screenings 
were done: i) Co-transfecting the cDNA libraries with a GFP reporter under the 
control of the Oct4 DE element (pDE-TK-EGFP). ii) Transfecting the libraries into 
Oct A cells, a HEK293 stable cell line which harbours the DE-TK-EGFP reporter. iii) 
Transfecting the libraries into primary fibroblasts obtained from a mouse harbouring 
Results 
33 
GFP reporter under the Oct4 promoter and iv) Sensitising the above screens with 5–
Azadeoxycytidine (Aza), a DNA demethylating agent; Trichostatin A (TSA), an 
inhibitor of histone deacetylases .  
3.1.1 Screening by using pDE-TK-EGFP reporter 
Oct4 promoter region has two important regulatory regions: Proximal Enhancer (PE) 
and Distal Enhancer (DE). A minimal construct containing the Oct4 DE element was 
sufficient for an enhanced TK promoter driven LacZ expression in the ES cells 
(Yeom et al., 1996). To allow for fluorescent reporter gene readout, I subcloned the 
DE-TK fragment into a pEGFP vector to generate a pDE-TK-EGFP reporter 
construct.  
Screening of Xenopus library by co-transfection of pDE-TK-EGFP reporter 
HEK293T cells were cotransfected with the Xenopus cDNA library pools, the pDE-
TK-EGFP reporter and a dsRed2 reporter. The EGFP expression was monitored every 
24 hours for 3 days post transfection. The dsRed2 expression served as an internal 
control for the transfection efficiency. Pools which increased the EGFP reporter 
expression were selected for further sib-selection. Following is a list of genes that 
were isolated by this method. Two of them, the growth arrest and DNA damage 
inducible protein alpha (Gadd45alpha) and FUSE binding protein (FBP) were of 
potential interest.  
Gadd45alpha is of interest because it was earlier identified in our lab in a separate 
screen designed to identify the genes that may mediate active DNA demethylation. 
FBP is interesting because of its reported expression pattern. It is expressed only in 
undifferentiated promonomyeloctic leukaemia cell line HL60 and the human 
monoblastic line U937. Upon differentiation, the expression of FBP is lost in these 
cells (Avigan et al., 1990; Bazar et al., 1995; Duncan et al., 1994). FBP is a sequence 
specific single stranded DNA binding protein. It was initially identified as a protein 
that bound to FUSE element present in the human c-myc promoter (Duncan et al., 
1994). Since Gadd45 was already under intense investigation in the laboratory, I 
focussed on the FBP and performed further experiments to validate if it is indeed a 
regulator of the Oct4 expression. 
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Pool No. Genes identified 
125-4.1A eef2-prov (elongation factor 2 ) 
125-4.1B actin, alpha cardiac 
125-4.2D cold-inducible RNA binding protein 2 
125-4.2E tyrosine kinase non-receptor 
125-4.2G tyrosine kinase non-receptor 
126-2 1E growth arrest and DNA damage inducible alpha 
161-3E MAP kinase activator XMEK3 
166-3 2F ribosomal protein L 11 
166-3 2H FUSE binding protein-like protein 
166-3.4D cadherin 3 type 1 preproprotein 
196-3.1A growth arrest and DNA-damage-inducible alpha 
196-3.1E gastrula zinc finger protein XLCGF57.1 
196-3.12F transmembrane 4 superfamily member 6 (Tetraspanin) 
196-4.5A ribosomal protein L10a 
196-4.5D MAP kinase activator XMEK3 
196-4.11A keratin 10,type 1, cytoskeletal 
Table I: Genes isolated upon co-transfecting Xenopus egg library with pDE-TK-EGFP 
reporter. 
Broadly two main approaches were taken: Overexpression of FBP in HEK293T cells 
and NIH3T3 cells to check if the endogenous Oct4 expression is induced and 
overexpression of dominant negative human FBP (dn-hFBP) (Duncan et al., 1996) or 
Engrailed–FBP fusion constructs to study if the endogenous Oct4 expression could 
be downregulated in the pluripotent P19 cells. 
Overexpression of the isolated xFBP activated the pDE-TK-EGFP reporter (Figure 
10, Panel A). However xFBP alone or in combination with Aza and TSA could not 
induce the endogenous Oct4 expression as analysed by RT-PCR in HEK293T cells 
(Figure 10, Panel B). It is to be noted that Aza and TSA treatment by itself could not 
induce the endogenous Oct4 expression in this specific cell line. 
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Figure 10: FBP activates the pDE-TK-EGFP reporter expression but does not affect the 
endogenous Oct4 expression. 
 Panel A: HEK293T was transfected with pDE-TK-EGFP (0,3 ng) with or without FBP (20 
ng-50 ng) in a 96 well plate. Total DNA transfected in each well was adjusted to 200 ng with 
PCS2+ plasmid and fluorescence was observed after 2 days.  
Panel B: HEK293T cells were seeded in 96 well plates and transfected with the 
reporter and 50 ng of xFBP or control PCS2+. Final amount of DNA transfected in 
each well was adjusted to 250 ng with PCS2+. Ten hours after transfection, 200 nM 
Aza and 50 nM TSA were added. 24 hours later, the medium was replenished with 
fresh Aza. FBP transfection was validated by the activation of the GFP reporter. 48 
hours after transfection, cells were lysed and Oct4 expression was analysed by RT-
PCR.  
Panel C: NIH3T3 cells were transfected with 120 ng xFBP or hFBP along with the 
pDE-TK-EGFP reporter. Total amount of DNA transfected in each well was made 
upto 250 ng with PCS2+. FBP transfection was ensured by the activation of the GFP 
reporter (not shown). 10 hours after transfection, Aza and TSA were added. 24 hours 
later, the medium was replenished with fresh Aza. 48 hours after transfection, cells 
were lysed and Oct4 expression was analysed by RT-PCR. BA=Beta actin.  
 
An earlier report had indicated that Aza and TSA treatment could induce Oct4 
expression in NIH3T3 cells (Hattori et al., 2004). In fact, TSA and Aza strongly 
induced the Oct4 expression (Figure 10, Panel C). The strength of the Oct4 induction 
decreases with lower doses of Aza and this could not be compensated by xFBP or 
hFBP (Duncan et al., 1996) overexpression. Thus xFBP or hFBP alone or in 
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combination with Aza and TSA could not induce the endogenous Oct4 expression in 
NIH3T3 cells. 
Figure 11: Dominant negative FBP does not reduce the Oct4 expression in P19 cells. 
Panel A: P19 cells were transfected with 250 ng of dominant negative hFBP (dn-hFBP) or 
Engrailed-FBP and 50 ng EGFP in a 24 well plate. Cells were immunostained using anti-
Oct4 primary antibody and Cy3 conjugated secondary antibody (secondary ab.). GFP 
expression traces the cells which are transfected. 
Panel B: P19 cells were cultured in 24 well plates and transfected with EGFP or dn-hFBP 
FBP (100-400 ng). Two days later, the cells were lysed and were analysed by Western blot 
using anti-Oct4 antibody.Tubulin served as a loading control. 
Panel C: Western blot analysis: Flag tagged Engrailed-FBP is expressed. 
 
Concerning the second approach, I observed that dn-hFBP overexpression has no 
effect on the endogenous Oct4 expression in P19 cells as analysed by Western blot 
(Figure 11, Panel B). It is to be noted that only about 20% of the P19 cells are 
transfected by the method employed. Hence any decrease in the Oct4 expression due 
to the transfection of dn-hFBP could be masked by the endogenous Oct4 present in 
the rest 80% of the untransfected cells. To rule out this possibility, Oct4 expression 
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was analysed by immunostaining P19 cells transfected with a mixture of dn-hFBP 
and EGFP. Transfected cells were marked by the GFP expression. The transfected 
cells (green) retain Oct4 expression (red) which is evident from the resultant yellow 
colour upon merging GFP and Cy3 images (Figure 11, Panel A top).  
As an alternative Loss-of-function approach, an Engrailed-FBP protein in which 
hFBP is fused to engrailed repressor domain (1-297) was used (Kessler, 1997; Smith 
and Jaynes, 1996). Like dn-hFBP, Engrailed-FBP also did not downregulate the 
endogenous Oct4 expression in P19 cells (Figure 11, Panel A bottom). Since 
overexpression of FBP did not induce the endogenous Oct4 expression in HEK293T 
and NIH3T3 cells and Loss-of -function approaches failed to repress the Oct4 
expression in P19 cells. Based on these results, I conclude that it is unlikely that FBP 
could play a role in the regulation of the Oct4 expression. 
To summarise, screening of the Xenopus library by co-transfection of the pDE-TK-
EGFP reporter resulted in the isolation of false positive genes. To minimise the false 
positives, the next approach was to generate HEK293 cells stably harbouring the 
pDE-TK-EGFP construct and use this cell line for screening. 
Screening of Xenopus library in HEK293/ pDE-TK-EGFP reporter cell line 
In order to generate a stable pDE-TK-EGFP reporter cell line, HEK293 cells were 
transfected with the pDE-TK-EGFP reporter and clones were then selected by G418 
resistance. Thirteen clonal pDE-TK-EGFP reporter cell lines, labelled Oct A to M, 
were generated. The next question was to select a suitable clone from among these 
thirteen cell lines in which transgene EGFP expression mimics the endogenous Oct4 
expression. Towards this end, the following approaches were taken: 
i) pDE-TK-EGFP cells were subjected to a reprogramming protocol (Hansis et al., 
2004) using Xenopus egg extract treatment and then GFP as well as the endogenous 
Oct4 upregulation were monitored. GFP expression was not seen in spheres and 
clustures obtained from any of the cell lines tested (data not shown). 
ii) Aza and TSA treatment can reactivate the expression of silenced genes (Cameron 
et al., 1999). So I treated all the clonal cell lines with a range of doses of Aza and 
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TSA to select the clones in which the transgene DE-TK-EGFP could be activated 
along with concomitant increase in the endogenous Oct4 expression. Out of thirteen 
DE-TK-EGFP clonal cells tested, GFP expression could be reactivated in two cell 
lines namely Oct A and Oct D (Figure 12, Panel A). I analysed the expression of 
endogenous Oct4 as well as the other pluripotency markers Rex-1 and GCAP by RT-
PCR. In comparison to the mock treated cells, Aza and TSA treatment did not 
upregulate Oct4 in either of the two cell lines (Figure 12, Panel B). Other tested 
markers were differentially affected. Rex-1 expression was induced strongly in Oct A 
cells and mildly in Oct D cells. Aza treatment alone, but not TSA or Aza and TSA 
combination induced the GCAP expression in both Oct A and Oct D cells (Figure 12, 
Panel B). 
Since the endogenous Oct4 was not upregulated upon Aza and TSA treatment in both 
the cell lines tested, it is possible to use either of them to screen the Xenopus cDNA 
library to isolate the genes that activate the transgene EGFP reporter expression. 
However the main caveat is any pool that could activate the EGFP expression should 
be further tested for its ability to upregulate the endogenous Oct4 expression. Thus 
Oct A cells were transfected with the Xenopus oocytes cDNA library pools (pool size 
of 300 clones). In order to sensitise the screening conditions, cells were resuspended 
in a medium containing 10 nM TSA 48 hours after transfection. Two pools were 
observed to upregulate the DE-TK-EGFP expression. Upon sib selection, 2 
independent clones, Cystatin and Hypothetical protein similar to human FLJ20729, 
were isolated. I further checked if co-transfection of the Cystatin and the FLJ20729 
could result in a synergistic increase of the DE-TK-EGFP expression. However this 
was not the case. (Figure 13, Panel A). 
The following experiments were done to validate the isolated clones. i) Transfection 
of Cystatin and FLJ20729 singly or their cotransfection alone as well as in 
combination with TSA treatment failed to upregulate the endogenous Oct4 in Oct A 
cells (Figure13, Panel C) or in HEK293T cells (data not shown). ii) Transfection of 
Cystatin and FLJ20729 did not upregulate the transgene EGFP expression in Oct D 
cells (Figure 13, Panel B). PCS2+LacZ served as a control for transfection efficiency 
in Oct D cells. iii) Cotransfection of Cystatin or FLJ20729 with the pDE-TK-EGFP 
reporter did not significantly upregulate the GFP expression in HEK293T cells (data 
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not shown). The results indicate that both the isolated cDNA clones were false 
positives. 
 
Figure 12: 5'-Azadeoxycytidine and Trichostatin A treatment reactivates pDE-
TK-EGFP expression in Oct A and Oct D cells. 
Panel A:  
Two pDE-TK-EGFP clonal cell lines (Oct A and Oct D) were incubated in a medium 
containing 500 nM Aza for 4 days. Since Aza is unstable at 37˚C, fresh Aza was added every 
day. On the last day of incubation, 200 nM TSA was added. Aza and TSA combination 
significantly reactivated the EGFP expression in comparison to untreated cells. 
Panel B: RT-PCR analysis in Oct A and Oct D cells treated with Aza and TSA. Oct4 was not 
upregulated upon combined Aza and TSA treatment in both Oct A and Oct D cells. However 
Rex-1 expression was induced. Aza treatment alone induced the pluripotency marker Germ 
Cell Alkaline phosphatase (GCAP) in both the cell lines. Beta actin (BA) expression was 
used for normalisation. 
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Figure 13: Cystatin and FLJ20729 overexpression in Oct A and Oct D cell lines.  
Panel A: Oct A cells were seeded in 24 well cell culture plates. 200 ng each of Cystatin or 
FLJ20729 was transfected alone or in combination. Final amount of DNA transfected was 
adjusted to 400 ng with PCS2+ in each well. Two days after transfection, 10 nM TSA was 
added and incubated for further 24 hours. Overexpression of Cystatin as well as FLJ20729 
activated the pDE-TK-EGFP expression. Transfection of Cystatin and FLJ20729 together did 
not synergistically increase the reporter pDE-TK-EGFP expression. 
Panel B: Oct D cells were transfected with 200 ng Cystatin or FLJ20729. Final amount of 
DNA transfected was adjusted to 400 ng with PCS2+ in each well. Two days after 
transfection, 10 nM TSA was added and incubated for further 24 hours. GFP reporter 
expression was not upregulated. In one of the wells, pCMV–LacZ was transfected and 
subsequently stained by X-Gal. This served as a transfection efficiency control for Oct D 
cells. 
Panel C: RT-PCR analysis of Cystatin and FLJ20729 transfected Oct A cells with or 
without TSA treatment. Beta actin (BA) expression was used for normalisation. Oct4 
expression was not upregulated in TSA treated as well as untreated cells.  
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3.1.2 Screening by using primary fibroblasts from 
Oct4/EGFP transgenic mice 
The previous results indicated that one of the key difficulties in screening for the 
reprogramming factors is to obtain a reliable Oct4 reporter cell line in which 
transgene expression faithfully mimicks that of the endogenous gene expression. This 
problem could be overcome by using primary fibroblasts isolated from a transgenic 
mouse, OG2, that harbours a GFP reporter inserted into an 18kb genomic fragment 
(GoF-18) encompassing the Oct4 gene. In this mouse, GFP expression is restricted 
only to germ cells and not observed in any somatic cells (Szabo et al., 2002) thus 
mimicking the endogenous Oct4 expression pattern. The next approach was therefore 
to use the primary fibroblasts from OG2 mice for the screening of the Xenopus cDNA 
pools.   
OG2 mice were a kind gift from Hans Schöler. Primary fibroblasts were isolated from 
the OG2 mice, at E14.5, expanded and frozen. As expected, no GFP expression was 
observed in these cells. The presence of the GFP transgene in fibroblasts was ensured 
by PCR (data not shown). A series of experiments was done to optimise the 
parameters to obtain better transfection efficiency. At maximum, about 40 percent of 
cells could be transfected.  
With the optimised transfection conditions, a Xenopus oocytes library was transfected 
alone or in combination with candidate pluripotency genes like BRG1, CBP, HMG-
CoA, and Oct4 to observe for the pools that may turn on GFP expression. 
Overexpression of Oct4 alone in somatic cells is insufficient to induce pluripotency 
(Hochedlinger et al., 2005). Nevertheless I decided to cotransfect pCMV Oct4 
construct with the Xenopus cDNA library pools expecting that this may promote a 
pluripotent state. The choice of the other three candidate genes for co transfection was 
based on the preliminary results of projects that were parallely carried out in the lab. 
CBP (Hansis, unpublished preliminary data) and BRG1 (Hansis et al., 2004) were 
implicated in nuclear reprogramming of somatic cells. HMG-CoA was one among the 
initial candidates obtained from another screen carried out to isolate proteins that may 
play an active role in DNA demethylation (Barreto, unpublished). On this basis, the 
following set of screens was done.  
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i) Pools of Xenopus oocytes library were co-transfected with pDsRed2 that encodes a 
red fluorescent protein and served as a control for transfection efficiency. 
ii) Pools of Xenopus oocytes were co-transfected with 3 ng each of BRG1, CBP, 
pDsRed2 
iii) Pools of Xenopus oocytes were co-transfected with 3 ng each of HMG-CoA, 
BRG1, CBP, pDsRed2 
iv) Xenopus oocytes were co-transfected with cDNA pools along with 8 ng pCMV 
Oct4, pDsRed2 
v) Xenopus oocytes cDNA pools were co-transfected with 8 ng pCMV Oct4, 3 ng 
each of HMG-CoA, BRG1, CBP, pDsRed2. 
In all the above cases 48 hours after transfection, 25 nM TSA was added to further 
sensitise the screening. Cells were observed by UV fluorescence for the GFP 
expression. However I could not isolate any Xenopus oocytes cDNA pool which 
could induce the GFP expression in OG2 cells by the above mentioned screening 
parameters (data not shown).  
Endogenous Oct4 readout 
3.1.3 Screening by using 293T cells with endogenous 
Oct4 readout 
The pDE-TK-EGFP reporter based approaches were not fruitful to isolate the 
regulators of Oct4 expression. As an alternative, I wished to use the endogenous Oct4 
instead of EGFP as readout in the screens. This would minimise the chances for 
isolating any false positive clones arising as an artefact of the reporter cell lines. 
However the main disadvantage of using this method is it is laborious; moreover only 
those pools which strongly induce the endogenous Oct4 could be isolated whereas 
weakly active pools could be missed out. Xenopus egg cDNA library pools were 
transfected into HEK293T cells. Two days later, the cells were analysed by Western 
blotting using anti-Oct4 antibody. Lysates from the P19 cells that expressed 
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endogenous Oct4 were used as a control for blotting. Tubulin expression was used as 
loading control. One representative blot is shown in the Figure 14. None of the cDNA 
pools could induce any endogenous Oct4 expression as analysed by Western blot. 
 
Figure 14: Xenopus cDNA library pools did not upregulate the endogenous Oct4 
expression in HEK293T cells. 
 HEK293T cells were transfected with Xenopus st10-30 cDNA library or oocytes cDNA 
library. Two days later, the cells were lysed in 30 µl NOP buffer and 40% of the lysate was 
resolved by a 12% SDS PAGE gel, blotted to a nitrocellulose membrane and immunodetected 
with anti Oct4 antibody. Lysates from P19 cells (lane 1) were included in each blot as a 
positive control for the immunodetection. The blots were stripped and reprobed using anti 
tubulin antibody which served as a loading control. 
3.1.4 Overview of screenings 
Cells Library used Read out Result 
HEK293T Oocytes and X.tropicalis egg 
library cotransfected with pDE-
TK-EGFP1 
Increase in GFP Signal False positives were 
isolated 
pDE-TK-EGFP1 
stable 293 cell line 
Oocytes library and TSA 
treatment 
GFP Signal False positives 
HEK293T X.tropicalis library Endogenous Oct4 
expression by Western 
blot 
No clones were 
isolated 
 
HEK293T Oocytes library and TSA 
treatment 
Endogenous Oct4 
expression by Western 
blot 
No clones were 
isolated 
OG2 fibroblasts 
(maintained in ES 
Medium) 
Oocytes library and TSA 
treatment 
GFP Signal No clones were 
isolated 
 
OG2 fibroblasts 
(ES Medium) 
Oocytes library + BRG1, CBP, 
TSA 
GFP Signal No clones were 
isolated 
OG2 fibroblasts 
(ES Medium) 
Oocytes library + BRG1,HMG 
CoA, CBP,TSA 
GFP Signal No clones were 
isolated 
OG2 fibroblasts 
(ES Medium) 
Oocytes library + pCMV Oct4 GFP Signal No clones were 
isolated 
OG2 fibroblasts 
(ES Medium) 
Oocytes library + pCMV Oct4, 
HMG CoA, BRG1,CBP,TSA 
GFP Signal No clones were 
isolated 
Table 2: Summary of different approaches used in the screening of Xenopus cDNA 
libraries for factors that upregulate the Oct4 expression. 
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The above table (Table 2) is a summary of different ways by which Xenopus cDNA 
libraries were screened for the factors that upregulate the Oct4 expression. However I 
did not isolate any clones that upregulated endogenous Oct4 by any of these methods. 
3.2 Screening of small molecules library 
Nuclear reprogramming of somatic cells has been achieved by nuclear 
transplantation, egg extracts treatment and cell fusion. Recently a small molecule 
named myo-reversine was found to dedifferentiate lineage-committed muscle cells to 
become multipotent mesenchymal progenitor cells, which can proliferate and 
redifferentiate into bone and fat cells (Chen et al., 2004). The discovery of myo-
reversine implies that chemical genomics may be used as a valuable approach to 
dissect the complex biological process of nuclear reprogramming (Ding and Schultz, 
2004). 
A chemical genomics screen was set up with the help of the DKFZ-EMBL core 
facility. A pilot screening of a library of ~3000 small molecules was performed in 
OG2 fibroblasts (chapter 3.2.1) and GoF-9 Luc cells (chapter 3.2.2) so as to find out 
any small molecules that could induce the Oct4 expression. 
3.2.1 Screening of the small molecules 
library using OG2 fibroblasts 
Fibroblasts obtained from E14.5 embryos of Oct4 GFP transgenic mice (OG2) line 
were used for screening the small molecule library. Induction of GFP fluorescence is 
used as the readout. Prior to the pilot screen, many parameters were considered for 
the optimisation of screening conditions. This includes i) Optimisation of Cell Culture 
conditions. ii) Optimisation of different methods for the GFP readout. 
Opitimisation of Cell Culture conditions 
The ability of the small molecules to induce the nuclear reprogramming of OG2 cells 
was monitored until 5 days post introduction of the chemical library. So it was 
necessary to optimise the initial plating density of cells so as to ensure a linear growth 
during the period of investigation. As the small molecule library was dissolved in 
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DMSO, I tested the tolerance of OG2 cells for the presence of DMSO in the growth 
medium. Moreover, serum albumin in the growth medium could interfere with the 
permeability of the small molecules into somatic cells. Therefore it is desirable to 
perform the screening in a medium with a reduced serum concentration. Thus I 
titrated the serum concentration to determine the minimal concentration that supports 
the normal growth of OG2 cells.  
Figure 15: Optimisation of cell culture conditions for the screening of small molecules 
library in OG2 fibroblasts. 
The parameters to be optimised were cell plating density, DMSO and FCS levels. OG2 
fibroblasts were plated at different densities in 96 well plates. Plating density of 2500 cells 
was found to support a linear growth of cells as shown in the panel. The cells were grown in a 
medium consisting of varying FCS and DMSO concentration as indicated. Cell proliferation 
was measured at the end of 2, 4, 6 days after the initial plating by luminometry using Vialight 
Cell proliferation/Cytotoxicity kit (Cambrex). Luminescence measured is directly 
proportional to the number of viable cells in the culture dish. 10% FCS supported the best 
growth rate whereas 3% FCS poorly supported the cell growth. DMSO, in the concentration 
range tested, did not exhibit any cytotoxicity. 
 
OG2 cells were plated at different plating densities. A range of DMSO concentration 
(1% to 0%, final concentration v/v) as well as serum (3%-10%, final concentration 
v/v) were tested that could support the linear growth for about 6 days in culture. The 
Growth kinetics was measured using Vialight Cell proliferation/Cytotoxicity kit. The 
luminescence obtained by this method is directly proportional to the healthy viable 
cells in the medium. From the data (Figure15), 
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i) DMSO had little effect on the growth kinetics of OG2 fibroblasts.  
ii) Initial plating density of 2500 cells ensured a linear growth curve for ensuing 6 
days of culture (data from other plating density not shown). 
iii) 3% FCS retarded the growth of OG2 cells whereas 10% FCS supported a 
maximal growth.  
Based on these data, 2500 cells were plated initially and the cells were grown in a 
medium containing 7.5% FCS for the screening. An empirical 3 µM of the small 
molecule library was added to the cells. The final DMSO concentration was 0.075% 
v/v.  
Optimisation of different methods for the GFP read out: 
The effect of small molecules on the OG2 cells was read out by the GFP 
fluorescence. Several options of detecting the GFP signal were considered i) by 
FACS; ii) by a plate reader; and iii) by microscopy. An ideal readout method must be 
able to measure even a very low GFP signal intensity over the background noise with 
a very high confidence. Any such readout method that has a very high limit of 
sensitivity would facilitate the identification of small molecules that may reprogram 
only very few OG2 fibroblasts. 
In order to test and select the best option for reading a GFP signal, I made use of 
NIH3T3/pDE-TK- EGFP stable cells for the preliminary optimisation experiments. 
This cell line was generated by transfecting pDE-TK-EGFP into NIH3T3 cells and 
then a selection with G418. As NIH3T3 cells are differentiated, pDE-TK-EGFP was 
not expressed in many clones obtained. However a leaky expression of the GFP was 
observed in few clones which were further expanded and propagated. The resultant 
stable cell line was heterogeneous and exhibited a mosaic, from strong to very weak, 
fluorescence expression pattern. 
In order to measure the limit of sensitivity of various GFP readout options, GFP 
expressing NIH3T3/pDE-TK-EGFP cells were serially diluted in GFP negative 
NIH3T3 cells. After 24 hours of incubation under standard culture conditions, GFP 
Results 
47 
signal was read by i) FACS; ii) Using a plate reader; iii) Using CellWoRx automated 
image analysis system 
FACS analysis was the best method. As few as 0.06 % GFP expressing cells amidst a 
population of non GFP negative background cells could be identified (Figure16, 
Panel A). Unfortunately, I could not employ FACS readout because of major technical 
difficulties in adapting the FACS protocol to a high throughput screening (HTS) 
format.  
 
Figure 16: Limit of sensitivity of different GFP read outs. 
GFP expressing NIH3T3/pDE-TK-EGFP cells were serially diluted in GFP negative NIH3T3 
cells as tabulated in the Panel A. After 24 hours, GFP was read by FACS (Panel A) or by 
using a plate reader (Panel C). By FACS, as little as 0.06% GFP expressing cells in a GFP 
negative background could be gated. However by using a plate reader, a background noise of 
about 100,000 fluorescent units was observed. In order to measure any significant signal with 
confidence over this back ground noise, a plating density of 1250 GFP expressing cells in a 
total of 40,000 cells (3.1%) is necessary. 
Panel B shows a representative GFP image obtained using automated fluorescence 
microscopy. Cells were stained by Hoechst dye (blue) and then images were taken using 
CellWoRx imaging system. Very rare GFP expressing cells in a background of non-GFP cells 
could be easily spotted with a high resolution.  
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When the fluorescence was measured using a plate reader, there was a significant 
background noise of about 100000 fluorescence units (Figure16, Panel C). To 
measure a significant signal over this noise with a high confidence, a plating density 
of 1250 GFP expressing cells in a total of 40,000 cells is necessary. On the 
assumption that both GFP expressing and non expressing cells have similar growth 
kinetics it could be inferred that a small molecule that induces nuclear 
reprogramming in as little as 3.1 % of OG2 cells could be detected using the plate 
reader. One major concern is very high error rates observed in the measured 
fluorescence intensity among replicates. When these plates were observed under a 
UV microscope (data not shown), the GFP cells were observed to be clustered. It is 
likely that this uneven distribution of GFP cells has resulted in high error rates. To test 
this possibility, I lysed the cells using a lysis buffer so that the GFP molecules are 
more uniformly distributed in the lysate and then measured the fluorescence using the 
plate reader. Four different lysis buffers were tested. i) Lysis buffer (Cambrex); ii) 
Passive lysis buffer (Promega); iii) NaCl lysis buffer (Cruciat et al., 2006) and iv) 
NOP buffer. The NaCl lysis buffer helped in obtaining a maximal fluorescence signal 
with very minimal standard deviations (11%) compared to 35% standard deviation 
observed when the GFP signal was read without lysing the cells (data not shown). 
With the initial optimised conditions, the small molecule screening was carried out. 
Briefly, OG2 fibroblasts cells were plated in a 96 well plate and 3 µM of each of the 
small molecule (n=3140) from the pilot library was added. After 5 days of incubation, 
the cells were washed with PBS and lysed using the NaCl lysis buffer. The 
fluorescence emission at 535 nm was read by a plate reader. However none of the 
small molecules tested could induce any GFP signal in the OG2 cells (data not 
shown).  
As an alternative approach, the GFP expression was observed by fluorescence 
microscopy using an automated CellWoRx imaging system. OG2 cells were plated in 
a 384 well plates and incubated with 3 µM chemical library for 5 days. The cells were 
stained by Hoechst dye and then fluorescence images at 488 nm (GFP) and 350 nm 
(Hoechst) channels were captured. NIH3T3/pDE-TK-EGFP cells were used as an 
experimental control (Figure16, Panel B). Once again, none of the small molecules in 
the pilot library could induce a GFP signal. 
Results 
49 
3.2.2 Screening of the small molecules library using a 
luciferase reporter 
In a HTS scenario, GFP reporter assays suffer from certain disadvantages: i) 
Quantitative measurements are difficult because of the background fluorescence from 
the cells and the reagents; ii) The lack of enzymatic amplification of GFP signal make 
it less sensitive and thus limiting its use to reporter constructs in which GFP is driven 
by a strong promoter (Naylor, 1999). These drawbacks could be avoided by using a 
cell line in which a luciferase reporter is driven by the Oct4 promoter as a tool to 
screen the small molecule library. Towards this purpose, GoF-9 Luc construct was 
generated in which the Luciferase (Luc) reporter is driven by a 9kb length complete 
mouse Oct4 promoter subcloned from the GoF-18 GFP (Yoshimizu et al., 1999).  
 
Figure 17: GoF-9 Luc is expressed in pluripotent cells but not in differentiated cells. 
Panel A:  Mouse ES (mES) cells were electroporated with 30 µg of linearised GoF-9 Luc or 
GFP Luc (Control) and were subjected to a G418 selection. The survived clones were lysed 
and different amounts of lysate (10 or 20 µg) were taken for quantification of the luciferase 
activity. GoF-9 Luc is expressed in mES cells.  
Panel B: 50 ng of GoF-9 Luc or GFP Luc (Control) was contransfected with 1 ng Renilla 
Luc in a 96 well plate. Total amount of DNA transfected was adjusted to 100 ng with PCS2+. 
Fire fly luciferase reporter assays were performed 48 hours after transfection using the Dual-
Luciferase Reporter Assay System and normalized after Renilla luciferase activity. GoF-9 
Luc is active in P19 cells but not in HEK293T.  
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GoF-9 Luciferase was expressed in pluripotent cells such as mouse ES cells and 
mouse embryonic P19 cells and it had a minimal basal expression in HEK293T 
immortalized cells (Figure 17). Clonal HEK293/GoF-9 Luc cells were generated by 
transfecting HEK293 with the GoF-9 Luc construct and further selection by G418 
resistance. Sixteen such clonal cells were obtained. In order to select a clonal cell line 
in which the luc reporter expression mimics the endogenous Oct4 expression, all 
HEK293/GoF-9 Luc cell line were subjected to nuclear reprogramming by Xenopus 
egg extracts (Hansis et al., 2004). After 5 days of incubation, the luciferase expression 
was measured (Figure 18, Panel A).  
 
Figure 18: Xenopus egg extracts did not upregulate the luciferase expression in 
HEK293/GoF-9 Luc clonal cells. 
Panel A: Each of the thirteen HEK293/GoF-9 Luc clonal cell lines were digitonin 
permeabilised and treated with Xenopus egg extracts. After 5 days of culturing, spheroids and 
clustures of cells were observed in eleven cell lines. They were lysed and luciferase 
expression was measured. Equal amounts of untreated and egg treated lysates from each cell 
line was analysed.  
Panel B: HEK293 cells were reprogrammed in parallel to analyse the efficiency of egg 
extracts used. RT-PCR analysis of spheres isolated from such cells is shown here. Oct4 is 
upregulated in the extract treated cells (Egg) than untreated cells (Con) and Beta actin (BA) 
is used as a loading control.  
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No significant upregulation of the luciferase expression was observed with any of the 
tested reporter cell lines. A slight upregulation of the luciferase expression was noted 
in clone 11. However the absolute value of luciferase expression measured was very 
low and fell within the range of background noise measured by the luminometer. So 
no specific clonal cell line could be selected by this approach. Oct4 upregulation as 
analysed by RT-PCR of HEK293 cells served as a positive experimental control 
(Figure 18, Panel B). 
As an alternative approach to select the best clonal cell line, I used reprogramming by 
cell fusion strategy. It was earlier reported that somatic cells could be reprogrammed 
into pluripotent state by a PEG mediated fusion with mouse P19 cells (Flasza et al., 
2003) I intended to select a HEK293/GoF-9 Luc stable cell line in which the 
luciferase upregulation mimics the endogenous Oct4 expression by this approach. 
Towards this end, I generated P19 cells that carry a puromycin resistance cassette 
(referred to as P19/puro). These cells were fused with each of the sixteen 
HEK293/GoF-9 Luc clonal cell lines that carry a G418 resistance cassette and then 
subjected to simultaneous selection with G418 and puromycin for 3 weeks. Unfused 
parental cells died whereas fused cells alone survived. Fusion colonies obtained from 
six of the sixteen HEK293/GoF-9 Luc clonal cell lines analysed namely # 2, 11, 7, 13, 
15, 16 alone survived the drug selection (Figure 19, Panel A). Each of these colonies 
was split into two and subjected to a luciferase expression analysis and RT-PCR 
analysis.  
None of the fusion colonies from cell lines # 7,13,15,16 show any upregulation in the 
luciferase expression (data not shown). However many fusion colonies obtained from 
cell lines # 2 and 11 upregulated the GoF-9 Luc expression (Figure 19, Panel B). 
Three colonies obtained with the cell line 2 and eight colonies obtained with the cell 
line 11 showed a significant upregulation of the luc expression. I intended to check if 
the endogenous human Oct4 is upregulated in these fusion colonies by RT-PCR 
(Figure 19, Panel C). Upon using SK 104/106 primer pair that specifically amplified 
human Beta actin (BA) ortholog for normalising the amounts of cDNAs to be used, I 
did not observe any specific BA expression. This prevented me from proceeding 
further to measure the expression of the human Oct4 ortholog in these fusion 
colonies. In contrast, BA  
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Figure 19: Poly Ethylene 
Glycol mediated fusion of 
HEK293/GoF-9 Luc cells and 
P19/puro cells. 
Panel A: The experimental Scheme is 
described. Each of the HEK293/GoF-9 
Luc clonal cell line (containing G418 
resistance cassette) was fused with 
P19/puro (containing puromycin 
cassette) cells by using poly ethylene 
glycol (PEG). The fused cells were 
selected under combined treatment of 
G418 and puromycin. Only successfully 
fused clones survived whereas unfused 
control cells died. Sixteen 
HEK293/GoF-9 Luc clonal cell lines 
were fused with P19/puro cells 
 
 Panel B: Luciferase expression was 
significantly upregulated in fusion 
colonies obtained from the cell line 2 
and the Cell line 11. Out of eleven 
fusion clones obtained with cell line 2, 
colonies 2(3), 2(8), 2(11) and out of 
twelve fusion clones obtained with the 
cell line 11, colonies 11(1), 11(4), 11 
(6), 11(7), 11(9), 11(10), 11(11), 11(12) 
showed a significant upregulation of the 
Luc activity over that of control 
unfused cells. Equal amounts of protein 
were taken for analysis in each lane.  
 
Panel C: RT-PCR analysis of fusion 
colonies. The objective was to check if 
endogenous human Oct4 is upregulated 
in those fusion colonies in which the luc 
transgene expression is upregulated. As 
a representative case, results of clones 
11(10), 11(11), 11(12) are shown here. 
The primer pair SK104/106 which 
specifically amplifies human (Beta 
actin) BA ortholog was used for 
normalisation. With this primer pair, BA 
expression was seen in control unfused 
cells but not in any of the fusion 
colonies. So I could not proceed to 
verify if the endogenous Oct4 (human 
ortholog) is upregulated. E270/E21 
primer recognises both mouse and 
human BA orthologs. With this primer 
pair, BA expression was seen in control 
as well as fusion colonies. –RT = Reverse 
Transcriptase negative samples. 
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expression was observed upon using a different primer pair (E270/271) that could 
amplify both mouse as well as human BA orthologs. The results indicate that in the 
colonies obtained by fusing mouse cell line P19 with human HEK293/GoF-9 Luc 
cells, mouse gene expression remains unaffected whereas expression of human genes 
is somehow affected. This result is in agreement with a old literature reporting the 
specific elimination of human chromosomes in human-mouse hybrid cells upon serial 
culture (Weiss and Green, 1967). When the experiments were designed in such a way 
that human counterpart is necessary for surviving a drug selection, it was observed 
that hybrid cells retained only a human chromosome or portion thereof that bears the 
essential gene that conferred drug resistance (Littlefield, 1964; Matsuya et al., 1968; 
Migeon and Miller, 1968). So it is highly likely that fusion colonies from 
HEK293/GoF-9 Luc and P19/puro cells retained only the human chromosome in 
which GoF-9 Luc cassette, and hence the G418 resistance gene, is integrated. 
However for want of time, I did not do any experiments to verify this possibility. I 
used cell line 11 for the pilot screen of the small molecule library. 
A small molecule screen was done in the following manner: 5000 GoF-9 Luc cells 
were plated in 96 well plates. Small molecule library was added at three different 
concentrations: 4, 12 or 32 µM. After incubation for three days, luciferase expression 
was measured. 
Out of 3140 small molecules tested, the majority of them had no effect (Figure 20, 
Panel B). Fifty eight small molecules upregulated the GoF-9 luciferase reporter 
(Figure 20, Panel A). However none of these small molecules dramatically increased 
the luciferase expression and at the maximum, a two fold upregulation of the reporter 
activity was observed.   
Only 35 out of the 58 lead small molecules could be successfully procured for further 
analysis. A dose response assay was performed in order to validate the results 
obtained in the pilot screen. Only 8 out of those tested small molecules could 
reproducibly upregulate the luc reporter. However, none of them could upregulate the 
endogenous Oct4 as analysed by RT-PCR (Figure 21).  
To conclude this part, I could not isolate any gene or small molecule that could 
upregulate the Oct4 expression in a somatic cell. 
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Figure 20: Small molecule screening in HEK293/ GoF-9 Luc Cells:  
Panel A:  About 5000 HEK293/GoF-9 Luc 11 cells were seeded in 96 well plates and 
incubated with 4, 12, or 32 µM of the small molecule library. A total of 3140 small molecules 
were screened. After 3 days of incubation, the luciferase expression was measured. The 
activity of the small molecule is estimated as % Relative Luciferase expression (Luciferase 
expression upon small molecule treatment/ Luciferase expression of control cells * 100) Fifty 
eight small molecules that upregulated the luciferase expression are listed. Based on their 
activity profile, these compounds were grouped under three headings. I. Decreasing activity: 
Those small molecules which are maximally active at 4 µM but toxic at higher 
concentrations; II. Increasing activity: Those small molecules which are active at higher 
concentrations; III. other small molecules which does not fit the category I or II. For easy 
reading, the % Relative Luciferase expression values are colour coded. Red denotes the 
maximum activity and white denotes the least activity. The intermediate activity profiles are 
denoted by yellow and saffron colours.  
Panel B: Histogram of luciferase expression profile obtained from the pilot screening of 
small molecules library in HEK293/GoF-9 Luc 11 cells. X axis: n, number of small 
molecules. Y axis: %  Relative Luciferase expression.  
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Figure 21: Validation of Hits obtained in the primary screen of small molecules library 
in GoF-9/Luc cells. 
Panel A: HEK293/GoF-9 Luc 11 cells were incubated with the lead small molecules 
shortlisted from the primary screen. A serial range of dose (from 50 µM to 0,02 µM) was 
tested for each of the candidates. Luciferase upregulation could be validated for only 8 small 
molecules. % Relative Luciferase expression obtained from the pilot screen as well as that of 
validation experiment is tabulated. 
Panel B: RT-PCR analysis for checking the endogenous Oct4 expression in HEK293/GoF-9 
Luc 11 cells after incubation with 8 of the validated small molecules (IDs of Small molecules 
# 1-8 as in the Panel A; Dose used: as in the Panel A under the maximal activity list). DMSO 
control, in duplicates and untreated cells (con) served as negative controls. None of the small 
molecules tested could upregulate endogenous Oct4 expression. BA, human Beta actin was 
used for normalisation. –RT refers to the Reverse Transcriptase negative samples. 
 
Part II: Gadd45 mediated DNA demethylation 
3.3 Gadd45 as a mediator of active DNA 
demethylation in Dnmt1
-/-
 cells 
Gadd45alpha was isolated in this laboratory by screening a Xenopus expression 
library for genes capable of promoting active DNA demethylation. Gadd45alpha 
overexpression activates methylation-silenced reporter plasmids and promotes global 
DNA demethylation. Gadd45alpha knockdown leads to DNA hypermethylation 
(Barreto et al., 2007).  
Results 
56 
 
Figure 22: Gadd45 activates reporter plasmids in Dnmt1
-/-
 cells. 
Transcriptional activation of methylated (Panel A) and unmethylated (Panel B) PCS2+ 
EGFP reporter in HEK293T cells and HCT116 Dnmt1-/- cells. Transient transfections were 
carried out in 96 well plates. A total amount of 100 ng DNA per well containing 25 ng 
PCS2+EGFP reporter in vitro methylated using the CpG DNA methylase from Spiroplasma 
sp. strain MQ1(M.SssI)) or 5 ng PCS2+ EGFP and 50 ng xGadd45alpha was transfected. 
Three hours later, 500 nM Aza was added to the indicated wells. 48 hours post transfection, 
photographs of GFP expressing cells were taken with an inverted fluorescent microscope.  
Panel C: Statistics of Gadd45/Aza activation of methylated as well as non-methylated 
PCS2+ EGFP reporter transfected in a HCT116 Dnmt1
-/-
 cells as observed by fluorescence 
microscopy. 
Panel D: Luciferase reporter assay of HCT116 Dnmt1-/- cells transiently transfected with a 
total of 100 ng DNA containing 20 ng fire fly luciferase reporter (PGL3) plasmid, 50 ng 
xGadd45alpha, 2,5 ng Renilla luciferase reporter plasmid in a 96 well plate. After three hours 
of transfection, 500 nM Aza was added in the indicated lanes. Reporter plasmids were 
produced in dam- and dcm- bacteria strain SCS110 and in vitro methylated using HpaII- and 
HhaI-methylase. Fire fly luciferase reporter assays were performed 48 hours after transfection 
using the Dual-Luciferase Reporter Assay System and normalized after Renilla luciferase 
activity. Error bars s.e.m, (n=3) 
 
One of the key questions I wanted to analyse was to check if Gadd45alpha mediates 
active rather than passive DNA demethylation. I overexpressed Gadd45 along with a 
GFP or luciferase reporter in HCT116 Dnmt1
-/-
 cell line in which the maintenance 
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methyltransferase Dnmt1 is mutated (Rhee et al., 2000). Gadd45alpha transfection 
activated the expression of methylated as well as unmethylated pCS2+ EGFP (Figure 
22). Similarly Gadd45alpha induced the activation of a methylated as well as an 
unmethylated luciferase reporter, SV40-Luc (Figure 22, Panel D).  
Aza is an inhibitor of Dnmt. In a cell line in which Dnmt is mutated, I reasoned that 
Aza would not activate the expression of a GFP reporter or SV40-Luc reporter and 
included it to serve as a negative control in the above experiment. Contrary to my 
expectations, Aza activated the unmethylated as well as methylated PCS2+ EGFP 
expression in the Dnmt1
-/-
 cells. Moreover, Aza activated the unmethylated SV40-Luc 
expression but not methylated SV-40 Luc (Figure 22).  
These results in HCT116 Dnmt1
-/-
 cells indicate that i) Gadd45alpha mediated 
activation is promoter- and reporter independent; ii) Gadd45 does not act by 
somehow affecting Dnmt1 maintenance methylation, thereby diluting methylation 
levels passively with each round of replication and iii) Aza could mediate 
demethylation via Dnmt1 independent mechanisms. 
3.4 Role of Gadd45 in muscle differentiation 
A Genome-wide loss of DNA methylation is usually associated with cellular 
differentiation. This is observed in early development of mouse embryos (Mayer et 
al., 2000; Oswald et al., 2000), differentiating myoblasts (Jost et al., 2001; Jost and 
Jost, 1994; Scarpa et al., 1996) Friend erythroleukemia cells (Adams et al., 1990; 
Bestor et al., 1984; Jost and Jost, 1995; Razin et al., 1988) and teratocarcinoma cells 
(Bestor et al., 1984; Razin et al., 1984). 
Given that Gadd45alpha has been implicated in active DNA demethylation (Barreto 
et al., 2007), I wanted to check if Gadd45 mediated DNA demethylation plays a 
significant role in cellular differentiation by using the mouse myoblasts 
differentiation as a model system. When the mouse myoblasts differentiates into 
myotubes, a genome wide demethylation occurs (Szyf et al., 1992), expression of 
Myogenin, a muscle specific transcription factor, is induced (Lucarelli et al., 2001; 
Scarpa et al., 1996). Demethylation of the 5'-flanking region of the promoter of the 
Myogenin gene precedes its expression (Lucarelli et al., 2001). 
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The Specific aims of this work are to establish the C2C12 muscle differentiation 
assay and to study the effect of siRNA mediated knockdown of Gadd45 on the 
promoter methylation status and expression of the Myogenin gene. 
 
Figure 23: Myogenin is induced upon differentiation of C2C12 myoblasts. 
Panel A: C2C12 myoblasts were plated in a 6 well plate in a growth medium (GM) 
containing DMEM and 10% FCS (Day -2). Two days later (Day 0), GM is replaced with 
differentiation medium (DM) consisting of DMEM and 2% Horse Serum. By Day 2, 
myotubes start appearing in the DM treated cells. They can be distinguished by their long 
tapering morphology. By Day 4, more C2C12 cells differentiate into myotubes. 
Panel B: Two days after the induction of differentiation, C2C12 cells were immunostained 
using anti-myogenin antibody and then with Cy3 conjugated secondary antibody. The nuclei 
were Hoechst stained. 
Panel C: Gene expression analysis of differentiating C2C12 myoblasts. Cells were treated as 
indicated in the Panel A. RNA was isolated from cells on Days -2, 1, 2 and 3. Expression of 
Myogenin, Gadd45alpha, Gadd45beta and Gadd45gamma were analysed by real time RT-
PCR. Myogenin is induced only upon addition of DM. Similarly, expressions of different 
Gadd45 genes are upregulated with the progression of the differentiation. 
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C2C12 myoblasts cells are normally grown in a growth medium (GM) consisting of 
complete DMEM medium supplemented with 10% FCS. Differentiation is induced 
by suspending the cells in a differentiation medium (DM) consisting of DMEM and 
2% Horse Serum (Figure 23, Panel A). The efficiency of differentiation achieved by 
this protocol is about 30% as analysed from immunostaining of Myogenin (Figure 23, 
Panel B). From Real time PCR analysis, Myogenin expression is observed to be 
induced and expression of all the three isoforms of Gadd45 is upregulated during the 
differentiation of C2C12 cells (Figure 23, Panel C).  
To analyse if Gadd45 is necessary for the differentiation of C2C12 cells, I knocked 
down Gadd45 alpha, beta, gamma using specific siRNAs against them. RNA and 
genomic DNA were harvested to study the gene expression and methylation status of 
the Myogenin promoter respectively. Knockdown efficiency of Gadd45gamma is 
poor (data not shown). Gadd45beta knockdown is efficient as observed from a 50% 
reduction in its transcript levels (Figure 24). With Gadd45beta knockdown, Myogenin 
transcript levels are significantly reduced. Expression of other isoforms of Gadd45 is 
not perturbed. With Gadd45alpha siRNA, a humble 30% reduction in its transcript 
levels was observed. It has no significant effect on Myogenin expression. 
 Using genomic DNA extracted from the above samples, methylation status of the 
Myogenin promoter was analysed by a HpaII/Methylation sensitive multiplex PCR 
(HpaII/MS multiplex PCR) assay in which methyl sensitive enzyme (HpaII) 
restriction is coupled to a PCR amplification. The assay yields an amplified product 
only if the DNA fragments that is to be amplified by specific pairs of primers fails to 
be cut by a restriction endonuclease. The analysis of the amplified products obtained 
from the HpaII-treated samples allows the determination of the methylation status of 
the single CCGG site in the 5'-flanking region of the Myogenin promoter. If a product 
is obtained, then the template is methylated. If there is no product, CCGG site in 
question is demethylated. Figure 25 shows the results of methylation patterns of the 
Myogenin gene as analysed by an HpaII/MS multiplex PCR.  
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Figure 24: siRNA mediated 
knockdown of Gadd45beta 
decreases the Myogenin 
expression. 
C2C12 cells were treated as in 
the Figure 23 except that they 
were transfected twice, on 
Days -2 and -1, with siRNA 
smart pools against Gadd 
45alpha (siGa), Gadd45beta 
(siGb) or control (siGlow). 5 
µM of fresh Aza was added to 
specific wells on each day. 
DM was added on day 0. 
Cells were harvested on days 
-1, 0, 2. Expression of 
Myogenin, Gadd45alpha, 
Gadd45beta, and 
Gadd45gamma were analysed 
by real time RT-PCR and 
normalised to the levels of 
Beta actin expression. Note 
that i) Myogenin expression 
was significantly upregulated 
with the addition of DM. Aza 
treatment did not affect the 
Myogenin expression. 
ii) Gadd45beta knockdown 
downregulated the Myogenin 
expression. 
iii) Gadd45alpha knockdown 
efficiency was poor and 
Myogenin expression did not 
change.  
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Figure 25: Gadd45beta knockdown blocks the demethylation of 5'-flanking region of the 
Myogenin gene as analysed by MS PCR.  
(top) schematic drawing of the Myogenin gene showing the relative positions of annealing of 
various primers used in the study. Arrows (a-h) indicate HpaII (CCGG) site.  
C2C12 cells were treated as in the Figure 23 except that they were transfected twice, on Days 
-2 and -1, with siRNA smart pools against Gadd 45alpha (siGa), Gadd45beta (siGb) or 
control siGlow (siCO). As an additional control, untransfected control (Con) cells were also 
included. 5 µM of fresh Aza was added to specific wells on each day that served as a positive 
control. DM was added on Day 0. Cells were harvested on Days -1(d-1), 0 (0d), 2 (+2d) and 
genomic DNA was isolated. The undigested DNA (Untreated) and samples digested with 
HpaII or MspI served as a template in multiplex PCR using P1M8 primer pair that amplifies 
5'-flanking region and P10M2 pair that amplifies exon 3 of the Myogenin gene that serves as 
a loading control. PCR products corresponding to sizes 499bp (5'-flanking) and 266bp (Exon 
3) were seen in all the lanes in undigested DNA samples. However 2 days after addition of 
the DM, demethylation is complete. This is blocked by siGadd45beta. MW= 100bp ladder 
 
Uncut control DNA samples (Figure 25 Untreated, lanes 2-16) produced two bands as 
expected: Upper one corresponds to the 5'-flanking region of the Myogenin promoter. 
The lower band is obtained by the amplification of exon 3 of the Myogenin gene that 
serves as a loading control for DNA being analysed. The 5'-flanking region is 
amplified in all the HpaII digested day -1 samples (Figure 25 HpaII, lanes 2-6). This 
shows that the 5'-flanking CCGG site of the Myogenin promoter of C2C12 grown in 
GM is methylated. 48 hours of incubation with 5 µM Aza induces a demethylation of 
CCGG site as evident from the absence of PCR amplification (HpaII, lane 9). Other 
day 0 samples grown in GM (HpaII, lane 7, 8, 10, 11) still remain methylated. 2 days 
after the addition of DM, the 5'-flanking site of the Myogenin promoter is 
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demethylated (HpaII, lanes 12, 13). Gadd45beta knockdown prevents the 
demethylation of this CCGG site (HpaII, lane 15) whereas Gadd45alpha knockdown 
has no effect (HpaII, lane 16). When HpaII is replaced by its methylation insensitive 
isoschizomer MspI digestion and then coupled with multiplex PCR, the formation of 
the upper band corresponding to the 5'-flanking region is inhibited (MspI, lanes 2-16). 
 
Figure 26: Gadd45beta knockdown blocks the demethylation of 5'-flanking region of 
the Myogenin gene as analysed by COBRA. 
The region between nucleotides 1191- 1549 of the Myogenin gene is being analysed. The 
359bp region is PCR amplified and cloned into a TOPO2.1 vector to obtain pMyogref 
construct and was then subjected to MssI invitro methylation. Unmethylated (U), fully 
methylated (M) and 1:1 ratio of unmethylated and methylated construct (U:M) were 
subjected to bisulphite conversion and then subjected to HpyCH4IV digestion (Panel A) and 
Hpy99I digestion (Panel B). The pattern of digestion products obtained with pMyogref 
served as a reference (Ref.).  
Genomic DNA was obtained from C2C12 cells in the experimental set up described in Figure 
25, bisulphite converted, PCR amplified and subjected to HpyCH4IV digestion (Panel A) and 
Hpy99I digestion (Panel B).  Initially (on d-1 and d0), the investigated DNA is a mixture of 
methylated and unmethylated alleles. Two days after the addition of DM (+2d), a complete 
demethylation is observed. This demethylation is prevented by siGadd45beta (siGb) but not 
by siGadd45alpha (siGa). Con, untransfected control cells; siCo, siGlow transfected.  
Further conformation was done by a COBRA assay (see materials and methods for 
details). Genomic DNA from the siGadd45 transfected C2C12 cells were bisulphite 
converted; nt 1191- 1549 of the Myogenin gene (M95800.1) which comprises 9 CpGs 
was amplified and then subjected to HpyCH4IV digestion (Figure 26, Panel A) and 
Hpy99I digestion (Figure 26, Panel B). The obtained results clearly show that 
Gadd45beta but not Gadd45alpha is required for the Myogenin promoter 
demethylation. 
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4 Discussion 
Part I: Screening for reprogramming factors 
The primary objective of this thesis was to identify nuclear reprogramming factors 
that would upregulate the pluripotency marker Oct4 expression in somatic cells. 
Towards this end, two broad screening strategies were employed. 
4.1 Screening of the Xenopus cDNA libraries 
Xenopus egg cDNA libraries were screened by overexpression in various cell lines to 
isolate the genes that would upregulate Oct4 expression The main readouts were i) 
GFP upregulation and ii) Endogenous Oct4 expression by Western blot. 
As a first screen, Xenopus egg cDNA libraries were co-transfected with the Oct4 
reporter plasmid pDE-TK-EGFP in HEK293T cells. Many of the isolated genes that 
upregulated the reporter activity were false positives (Table 1; Figures 10 and 11). It 
is possible that the immortalising t-antigen of HEK293T cells could bind to the SV40 
Ori present in the reporter construct resulting in an episomal replication. This along 
with the observed background expression of the reporter plasmid may have 
contributed to the isolation of many false positive candidates. 
The next screen was done in HEK293 stable cell line harbouring pDE-TK-EGFP 
reporter construct. Two clones, Cystatin and FLJ20729, were found to activate EGFP 
activation. However these clones did not activate the endogenous Oct4 and failed in 
other validating experiments leading me to conclude that the isolated clones were 
false positives (Figure 13). The choice of the reporter cell line is a major concern. 
This cell line was selected on the basis of EGFP activation by Aza and TSA treatment 
(Figure 12). However no concomitant upregulation of the endogenous Oct4 
expression was observed. It is possible that in this cell line, the pDE-TK-EGFP 
transgene had integrated into a locus that is amenable to Aza treatment and hence the 
observed reporter activation is more reflective of the geography of the transgene 
location.  
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The next set of screens was done using the primary OG2 fibroblasts. Xenopus oocytes 
library was transfected alone or in combination with probable pluripotency 
facilitators like Oct4 (a stem cell marker), BRG1 (necessary factor for nuclear 
reprogramming), HMG-CoA and TSA (chromatin modifiers). I did not isolate any 
genes that upregulated the GFP expression. 
The next approach was to move away from using GFP as readout and to monitor 
expression changes directly at the level of endogenous Oct4 by Western blot (Figure 
14). I did not isolate any clones by this approach. 
4.2 Screening of the small molecules library 
The greatest advantage with this chemical genomics approach is the availability of a 
huge repertoire of synthetic molecules. This increases the probability of finding a 
candidate molecule mediating the desired cellular function.  
A library of about 3000 small molecules available at the DKFZ-EMBL chemical 
genomics core facility was screened in OG2 cells to isolate the small molecules that 
may upregulate the GFP fluorescence. I did not find any such small molecule. As an 
alternative, the screen was repeated in HEK293/GoF-9 Luc clonal Cell line 11 to 
screen the small molecule library. Eight small molecules did show very modest 
upregulation of the luciferase activity but none of them did upregulate endogenous 
Oct4 expression by RT-PCR (Figures 20 and 21). It is possible that the reporter 
upregulation observed with the small molecules could be cell line specific artefact 
arising out of the genomic loci of integration of the transgene.  
 One major concern with the latter screen is the choice of the reporter cell line. These 
cells were selected on the basis of observed upregulation of the luc reporter in several 
but not all colonies obtained after chemical fusion with pluripotent P19 cells and 
subsequent drug selection. The RT-PCR analysis indicated that the endogenous genes 
of human counterpart were suppressed (Figure 19). It is already reported that in 
mouse-human cell fusions, the human chromosomes were progressively lost 
(Matsuya et al., 1968; Migeon and Miller, 1968). So it is possible that in 
P19/HEK293 GoF-9 Luc fusions all the human chromosomes except the region 
conferring G418 resistance which is necessary for the survival were lost. Had I used 
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human N-Tera2 cells as the pluripotency partner, instead of mouse P19 cells, I could 
have overcome this problem. However even in that scenario, it would be difficult to 
distinguish between the upregulation of human Oct4 of the HEK293T cells from the 
background human Oct4 contributed by NTera2 cells. As an alternative, mouse 
somatic cells could be used to generate transgenic reporter cell lines and then could 
be subjected to fusion with NTera2 cells.  
4.3 ‘SWOT’ analysis of the screening for 
reprogramming factors 
SWOT Analysis is a strategic planning tool used to evaluate the Strengths, 
Weaknesses, Opportunities, and Threats involved in a project or in a business venture 
or in any other situation of an organization or individual requiring a decision in 
pursuit of an objective (http://en.wikipedia.org/wiki/SWOT). Here, I have attempted 
to do a SWOT on this screening for elusive reprogramming factors hoping that it 
would be useful for designing fresh screening strategies tabula rasa. 
1.Strengths: As against the general tendency of avoiding high risk projects, this lab 
encourages to use off-the-beaten track approaches to find answers to some of the 
challenging problems in the developmental biology. The high quality of Xenopus 
expression library, exemplified from the discoveries made using it (Barreto et al., 
2007; Davidson et al., 2005) is a definitive strength. DKFZ-EMBL chemical biology 
core facility nurtures any chemical genomics projects ab initio.  
2.Weakness: The fulcrum of a screening project resides on the library being 
screened; the cells being used; the methodology of screen and readout being 
employed. As the quality of the libraries employed is assured, I would discuss other 
two points largely from the point of view of the results obtained with this thesis. 
 Cell lines: i) I principally used HEK293 cells and murine embryonic fibroblasts. The 
problem with both of them is they are far highly differentiated. Even Xenopus egg 
extract treatment could not completely reprogram HEK293T cells (Hansis et al., 
2004). Moreover forced expression of factors like Yamanaka genes were not highly 
efficient in reprogramming mouse embryonic fibroblasts into pluripotent cells. Given 
this, extremely differentiated cells may not be very ideal for screening for 
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reprogramming factors. Adult progenitor cells or differentiated cell lines like 
C3H10T1/2 which has shown multipotential capability could be considered as 
suitable alternatives. 
ii) Most of the screens were done in a Oct4 reporter cell lines in which reporter 
activity did not mimic the endogenous Oct4 expression. This has resulted in the 
isolation of genes or small molecules which turned out to be cell-line specific 
artefacts.   
iii) A readout that favours single cell analysis should be used. Most of the work relied 
on GFP by microscopy in which such analysis was possible. However in the screen 
done to read endogenous Oct4, Western blot analysis was used. As immunostaining 
allows the gene expression studies at a single-cell level, would have been more 
insightful. However, it should be noted that the local concentration of protein should 
be significantly high to be analysed by immunostaining. 
iv) One more key weakness is I relied exclusively on Oct4 as the read out. Instead, 
upregulation of a combination of pluripotency markers as readout could have been 
used. 
3.Opportunities: Reprogramming factors would definitely help us in widening our 
academic knowledge of the mammalian developmental biology. They would be of 
high use in therapeutics and probably may help us usher into an era of personalised 
medicine.  
4. Threats: 
a. Threat of hypothesis: Are there any master regulators for puripotency? If they 
exists they should be able to convert a differentiated cell into a pluripotent cell. 
However no such genes have been described yet and unless identified they would 
remain ipse dixit. At least, the identification of Yamanaka genes is comforting that it 
is possible to reprogram somatic cells into stem cell state to an extent by a defined 
cocktail of genes.  
b. Other Threats: This is materialistic: It is always possible that hit or miss projects 
like this could fail to translate into a scientific publication.  
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The fundamental objective of doing this SWOT is to minimise the weakness 
associated with the project and maximise the strengths. Following ideas may be 
considered in this pursuit. 
i) The priority should be in developing a reliable tool for reprogramming assay rather 
than the screen itself. One could try to reprogram adult progenitor cells as well as 
multipotential cells like C3H10T1/2, C2C12 or hematopoeitic cells using Xenopus 
egg extracts; forced expression of Yamanaka genes and cell fusion with pluripotent 
cells. It is highly possible that these cells are more efficiently reprogrammable than 
293T cells. One can investigate if the efficiency of reprogramming could be increased 
by subjecting the cells to more than one round of Xenopus egg extracts treatment.   
ii) Once a best reprogrammable cell line is selected, then reporter cell lines could be 
generated. Effort should be to generate multi-reporter cell line. For example a cell 
line harbouring Oct4-geo/Sox2-RFP/Nanog–GFP could be generated. Upon 
reprogramming, such a cell line should express beta galactosidase, survive G418 
selection, and upregulate GFP and RFP expression. Moreover, the endogenous Oct4, 
Nanog, Sox2 should be upregulated.  
iii) Once the above reprogrammable tool is available, then isolating the 
reprogramming factors should be achievable. Several screening strategies can be 
considered. For example, a) Reprogramming by Xenopus extracts would confer G418 
resistance in the reporter cell line. The unrestrictive availability of Xenopus eggs 
makes them the easily available totipotent proteome source. Reprogramming factors 
could be isolated by the biochemical fractionation approaches. b) Inorder to cover the 
complete genome, atleast 50,000 genes of the Xenopus expression cDNA libraries 
(that are available in the lab) should be screened. 50 pools of 1000 cDNA clones 
could be transfected alone or in sequential combination with others (pool 1 with pool 
2; pool 1 with pool 3 and so on) and select those pools that confers resistance to G418 
selection. Moreover in such cells GFP and RFP reporters should as well get activated. 
c) Another modification that could be considered is to prime the reporter cell line by 
reprogramming the cells with a sub-optimal dose of Xenopus egg extracts and then 
use such ‘primed cells’ for library screening. d) Other two peculiar features of stem 
cells that could be exploited are – short G1 phase in stem cells and the enormous 
tolerance of ES cells for a 3-fold reduction in levels of genomic m
5
C. Are there any 
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somatic cell lines which have unusually shorter (than usual) G1 phase? If so they 
could be considered for reprogramming assay as well as a tool for screening. Xenopus 
cDNA library transfection could be combined with siRNA knockdown of DNA 
methyl transferases or knockdown of Rb components as well.  
Part II: Gadd45 mediated DNA demethylation 
4.4 Gadd45alpha in DNA demethylation of 
Dnmt1-/- cells 
Gadd45alpha was discovered in this laboratory to have a DNA demethylation 
activity. Several experiments reported in this study (Barreto et al., 2007) indicate that 
Gadd45 acts by active demethylation. Apart from these experiments, I overexpressed 
Gadd45 in HCT116 Dnmt1
-/-
 cell line in which the maintenance methyltransferase 
Dnmt1 is mutated (Figure 22). Gadd45 induced the GFP as well as luciferase reporter 
activation in these cells. This indicates that Gadd45 does not act by affecting Dnmt1 
maintenance methylation, thereby diluting the methylation levels with each round of 
replication. Obviously it would have been more informative if I were able to show 
Gadd45 mediated demethylation in a compound knock out cells in which Dnmt1 as 
well as Dnmt3 have been depleted. However these cells were poorly transfectable 
(data not shown) making such analysis difficult. 
One interesting out come of this set of experiments was obtained with Aza treatment. 
Reasoning that Aza should not activate a reporter construct in a methyltransferase 
negative background, I included it to serve as a negative control. Surprisingly Aza did 
activate unmethylated GFP and luciferase reporters as well as methylated GFP 
reporter but not methylated SV40-Luc. This observation is puzzling and probably this 
discrepancy could arise due to difference in the absolute levels of methylation of 
these two constructs. It is possible that SV40-Luc construct is heavily methylated and 
probably requires higher dose of Aza to relieve of its methylation. More experiments 
are necessary to validate this finding that Aza could mediate demethylation by Dnmt1 
independent mechanisms. Indeed, Aza treatment has been shown to activate the 
Gadd45 expression (Schneider-Stock et al., 2005). It is possible that in Dnmt1
-/-
 cells, 
such a Gadd45 induction by Aza could mediate reporter activation. This claim could 
be verified by analyzing the reporter activity after knocking down Gadd45 in Dnmt1
-/-
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cells treated with Aza. However those experiments are beyond the scope of this thesis 
study. Recently a truncated Dnmt1 protein which retains a hemimethylase activity has 
been reported in HCT116 Dnmt1
-/-
 cells (Egger et al., 2006; Spada et al., 2007). 
Dnmt1
-/- 
cells being hypomorphs for Dnmt1, this may mask the real phenotype as one 
would expect from a complete Dnmt 1 knockout in these cells.  
4.5 Role of Gadd45 in muscle differentiation 
Demethylation of individual genes has been observed during cell type specific 
differentiation, a necessary step in the process of tissue specific transcriptional 
activation. I tested if Gadd45 plays a role in development using in vitro differentiation 
of C2C12 myoblasts as a model system.  
All the three isoforms of Gadd45 were expressed in C2C12 myoblasts. When induced 
to differentiation, upon serum starvation, their expression levels were significantly 
upregulated (Figure 23). This result is in confirmation with an earlier publication that 
reported an increased Gadd45alpha during muscle differentiation (Cam et al., 2006). 
It is possible that Gadd45 is upregulated because of the serum starvation induced 
stress response and does not have any direct ramifications on muscle differentiation. 
This probability is discounted by the fact that knockdown of Gadd45beta reduced the 
Myogenin induction (Figure 24). This is because of inhibition of the demethylation of 
the myogenin promoter as analysed by MS-PCR and COBRA assays (Figures 25 and 
26). There are 23 CpG dinucleotides present in the 5'-flanking region of the 
Myogenin promoter. Out of these, the one at nt position 1233 is a part of HpaII site 
hence easy to analyse its methylation status by MS-PCR. It was reported earlier this 
site undergoes demethylation during C2C12 differentiation (Lucarelli et al., 2001). I 
have found that Gadd45beta knockdown prevented the observed demethylation at 
this site (Figure 25). To analyse the methylation status of other CpGs, one needs to 
employ techniques like bisulphite sequencing or COBRA. However both these 
methods suffer from inherent disadvantages: The bisulphite sequencing method is a 
labour intensive and time consuming whereas the scope of COBRA analysis is 
limited by the availability of appropriate restriction enzymes. I was able to design 
COBRA assay for analysing three other CpGs (1339-CGACG-1443 by Hpy99I and 
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1448-ACGT-1551 by HpyCH4IV) and found that these sites as well undergo 
Gadd45beta mediated demethylation during C2C12 differentiation (Figure 26).  
From the above discussion, I could conclude that Gadd45beta is necessary for the 
demethylation of the Myogenin promoter during C2C12 differentiation which leads to 
the induction of Myogenin expression.  
Open Questions: 
This observation leads to many open questions to be analysed in order to conclude the 
role of Gadd45 in muscle differentiation: 
i) Out of siRNA reagents against three different Gadd45 isoforms, Gadd45beta 
siRNA alone is very efficient as evident from its ability to significantly decrease the 
Gadd45beta transcript levels. However the knockdown efficiencies obtained with 
siRNA reagents, under the conditions used, against Gadd45alpha (Figure 24) and 
gamma (data not shown) are poor. It is necessary to use different siRNA 
concentrations as well as reagents from different suppliers to obtain a high efficient 
knockdown of alpha as well as gamma isoforms in order to rule in or rule out their 
role during C2C12 differentiation. 
ii) Does Gadd45beta affect the entire myogenesis program or is it Myogenin promoter 
specific? As a result of myogenesis, muscle specific creatinine kinase (CK) activity is 
upregulated in the myotubes (Lucarelli et al., 2001). One could address if the 
Gadd45beta knockdown reduces such a CK activity. Earlier reports have indicated 
that global DNA demethylation occurs during muscle differentiation. What would 
happen to such a demethylation when Gadd45beta is inhibited could be analysed. 
iii) Gadd45beta is present in C2C12 before the induction of differentiation, however 
the Myogenin promoter remains methylated in these cells. Probably, Gadd45beta 
protein is not targeted to the methylated loci at this stage. With the induction of 
differentiation, the targeting complex could be triggered to load the Gadd45 to an 
appropriate methylated locus. Two questions that need to be addressed are: a) To 
analyse by Chromatin IP if Gadd45beta is recruited to the methylated loci in the 
Discussion 
71 
Myogenin promoter; b) What factors contribute to such a differential targeting during 
normal growth and upon induction of differentiation could be addressed. 
Mechanism: 
If Gadd45 is implicated in muscle demethylation what would be the mechanism of 
action? 
 
Figure 27: Model for DNA 
demethylation during in vitro muscle 
differentiation. 
Both nucleotide excision machinery 
(NER) and base excision machinery 
(BER) may be involved in 
demethylation.  
 
 
 
 
Gadd45beta knockdown in human RKO cells affects MLH1 promoter demethylation 
and hence its transcriptional activation. Moreover, Gadd45beta siRNA knockdown in 
HeLa and RKO cells induces global DNA hypermethylation. Similar results were 
observed with Gadd45alpha knockdown (Barreto et al., 2007). Hence it is highly 
possible that Gadd45beta mediates DNA demethylation like Gadd45alpha via 
nucleotide excision mechanism (NER). Moreover in G8 mouse myoblasts cells, 
maximal loss of DNA methylation
 
is attained after 2 days of differentiation, followed 
by a gradual
 
remethylation. During this period, other changes were also noted: DNA 
methyl transferase activity and DNA synthesis decreased. Moreover a number of 
hemimethylated DNA strands increased along with increased methylcytosine 
glycosylase activity (Jost et al., 2001; Jost and Jost, 1994). Taken together, it is 
possible that C2C12 genome demethylation may involve NER via Gadd45 as well as 
base excision repair (BER) via methyl cytosine glycosylase. Such a model accounts 
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for the rapid active demethylation observed in the Myogenin promoter immediately 
after the induction of differentiation as well as high DNA glycosylase activity 
observed later during differentiation in G8 myoblasts. The observed reduction in 
DNA methyltransferase activity may prevent the remethylation of actively 
demethylated DNA strands.  
The proposed model could be further validated by analysing if other components of 
NER and BER machinery affect C2C12 differentiation. 
Role of Gadd45 in development in vivo 
What is the role of Gadd45 in development in vivo? In zebrafish, Gadd45beta is 
implicated in the somite segmentation (Kawahara et al., 2005). In mouse, 
Gadd45beta has been shown to be necessary for chondrogenesis (Ijiri et al., 2005). 
Xenopus Gadd45gamma is shown to be necessary for neurogenesis (de la Calle-
Mustienes et al., 2002). In mammals, Gadd45alpha
-/- 
(Hollander et al., 1999), 
Gadd45beta
-/- 
(Lu et al., 2004), Gadd45gamma
-/- 
(Hoffmeyer et al., 2001) mice grew 
to adulthood without showing severe phenotypic differences from their wild-type 
littermates. This indicates that Gadd45 deficiency has no effect on normal mouse 
development. The main lacuna in analysing these mouse lines is that each of them is 
deficient only in one Gadd45 isoform. It is possible that this deficiency is 
compensated by the presence of the other two isoforms so that the required Gadd45 
threshold that supports a normal development could be maintained. This necessitates 
the analysis of development in mice in which all three isoforms have been knocked 
out. As another suggestion if a dominant negative Gadd45 is available, it could be 
used to generate conditional mouse lines so as to study the role of Gadd45 in 
development. 
This raises another question: Is any such Gadd45 dosage compensatory mechanism 
observed in vitro in cell culture? Gadd45alpha knockdown or Gadd45beta 
knockdown alone is sufficient to cause genome hypermethylation in RKO and HeLa 
(Barreto et al., 2007) and promoter hypermethylation in C2C12 cells (Figures 25 and 
26). When Gadd45beta is knocked down in C2C12 cells, Gadd45alpha and gamma 
transcript levels were similar to that of the control transfected. These observations 
indicate that such compensatory mechanisms may not exist in vitro. 
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To conclude, the primary objective of this thesis to isolate genes which may 
reprogram somatic cells into stem cell state remained unfulfilled and the second 
objective to investigate the role of Gadd45 in the in vitro differentiation of myoblasts 
shows some promising trends.  
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5 Materials and Methods 
5.1 Equipments and materials 
5.1.1 Equipments 
 
PCR thermocyclers (MJ Research), heating blocks (Eppendorf), centrifuges and 
microcentrifuges(Heraeus, Sorval, Beckman), fluroescent microscope (Nikon), digital 
cameras (Sony, Visitron Systems), spectrophotometer (Beckman), luminometer 
(luminoskan Ascent, labsystems), power supplies (Biorad, Consort), gel UV photo 
documentation (Biostar and Intas) , electroporator (BioRad), balances (Sartorius, 
Kern), photolaboratory (Agfa), micropipettes (Gilson), multi-channel pipettes, 
vortexes, agarose gel and PAGE minigel chambers, microwave oven , shakers, rotars, 
homogenisors, Neubauer cell counter, humidified incubators for cell culture, light 
Cycler 480 (Roche). 
5.1.2 Materials  
a) Reagents and consumables 
Reagents and consumables were bought from Biochrom AG, Bio-Rad, BioZym, 
CalBiochem, Eppendorf, Falcon, Fluka, Fuji, Gibco, Invitrogen, Kodac, Labstar, 
Nunc, Merck, Sartesdt, Serva, Sigma, Roche, Roth, Whatmann and others: 
Acetic Acid; Agar; Agarose; Ampicillin; Aprotinin; ATP; Blocking reagent; BSA; 
chloroform; Copper sulphate; Complete,mini protease inhibitor cocktail; Creatine 
Phosphate; Creatine Kinase; Cytochalasin B; DEPC; Digitonin; DMEM; DMSO; 
dNTPs; EDTA; EGTA; Ethanol; Ethidiumbromide; FCS; Fugene6; G418; Glycerol; 
Glycogen; HEPES; Hoechst reagent; Horse Serum; Hydrochloric acid; Isopropanol; 
Kanamycin; Leupeptin; LIF; Magnesium acetate;Magnesium chloride; PBS (cell 
culture grade); Pepstain A; Phenol; PEG 1500; Potassium acetate; Potassium 
chloride; Potassium hydroxide; Puromycin; rRNA; RNAguard; SDS; Sodium acetate; 
Sodium glutamate (cell culture grade); Sodium hydroxide; β-mercaptoethanol; Triton 
X-100; Trypsin-EDTA; Tween20; X-gal; X-ray film etc. 
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b) Enzymes and special kits 
Enzymes - DNase I; Proteinase K; RNase A; Restriction enzymes; T4 DNA ligase, 
Taq DNA polymerase , in vitro methylating enzymes etc were brought from New 
England Biolabs, Promega, Fermantas, Invitrogen and Roche. 
Special Kits – Accuprime Taq polymerase system (Invitrogen); DNeasy blood & 
tissue kit (Qiagen); Epitect Bisulphite kit (Qiagen); Expand High fidelity PCR system 
(Roche); Qiaprep spin mini-prep kit  (Qiagen); Qiaprep midi -prep kit (Qiagen); 
Qiaquick PCR purification kit (Qiagen); TOPO cloning kit (Invitrogen), ViaLight cell 
proliferation/cytotoxicity kit (Cambrex) etc.  
c) Cell lines  
HEK293T; HEK293; NIH3T3; P19; C2C12; HCT116 Dnmt1
-/-
. Apart from these 
cells, following reporter cell lines were generated and used in this study (Table III). 
Name 
 
Parental 
Cell line 
Transgene 
 
Comments 
 
HEK293/GoF-9 Luc 
(clone11) 
HEK293 
 
GoF-9 Luc 
 
Clonal 
 
Oct A and Oct D HEK293 pDE-TK-EGFP Clonal 
NIH3T3/pDE-TK-EGFP 
 
 
NIH3T3 
 
 
pDE-TK-EGFP 
 
 
Non-clonal and 
selected for GFP 
expression. 
OG2 fibroblasts 
obtained from OG2 mice 
(Szabo et al., 2002). 
 
Fibroblasts 
 
 
 
GoF-18 GFP  
 
 
 
Primary cells.  
No GFP expression 
is seen in these 
cells.  
P19/pur P19 pPur Non-clonal 
Table III: Reporter cell lines used in this study. 
 
d) Antibodies 
Mouse anti tubulin cl.512 (Sigma); Oct4 antibody SC-5279 (Santa Cruz); Mouse anti 
myogenin monoclonal antibody, clone F5D (Abcam); Anti mouse Cy3 (Dianova)  
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e) Libraries 
i) Xenopus oocytes cDNA expression library: This is a complementary DNA library 
prepared with Xenopus tropicalis oocytes mRNA.  
ii) XtSt10-30 cDNA expression library: This is a Xenopus tropicalis complementary 
DNA library prepared with mRNA from embryos at stage 10, 20 and 30. Individual 
colonies (100,000) were arrayed in 384-well plates and, from each plate, four sets of 
96 colonies were combined to prepare plasmid DNA pools. Both these Xenopus 
cDNA libraries were generated by W. Wu  
iii) Small molecule library: This library is available at the DKFZ-EMBL chemical 
genomics core facility. The complete library has 55,000 compounds drawn  from 
Tripos Leadscreen collection and form the laboratory of Prof. A. Giannis, University 
of Leipzig. A minimal library consisting of about 3140 compounds representing the 
spectrum of the complete library is used for the pilot screening.  
f) Constructs 
pDE-TK-EGFP: pDE-TK-LacZ (Yeom et al., 1996) was used as the parental 
construct. DE-TK region was amplified by a high fidelity PCR kit ;digested with 
Asp718/SmaI and ligated into pEGFP-1 (Clonetech). 
GoF-9 Luc: GoF-18 EGFP (Yoshimizu et al., 1999) construct is digested with NotI to 
release 18 kb Oct4 elements including the regulatory regions, EGFP transgene and the 
coding sequence. This 18kb fragment is digested with Asp718 to obtain a 9kb 
fragment (GoF-9) that exclusively consists of Oct4 regulatory regions which was then 
inserted into a modified pEGFP1 construct from which EGFP casette was removed 
and luciferase coding sequences from PGL3 was inserted to yield a GoF-9 Luc. 
Engrailed-FBP:Engrailed was obtained from Eng-Sia construct (Kessler, 1997). FBP 
was PCR amplified from hFBP expression construct (Duncan et al., 1996) and then 
inserted in frame into a Flag-PCS2+ construct. 
Other constructs that were used are: 
pPUR (Clonetech)  
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pDSRed2-N1 (BD biosciences) 
pCMV Oct4 (Tomilin et al., 2000) 
pCMVmCBP (Chrivia et al., 1993) 
pBS(KS+)CeBRG1 (de La Serna et al., 2000);  
pCR 2.1-TOPO (Invitrogen)  
SV-40 Luc and pCMV-EGFP -unmethylated as well as in vitro methylated constructs 
(Barreto et al., 2007). 
g) siRNA  
siRNA smart pools were designed using http://www.dharmacon.com/ 
sigenome/default.aspx. Smart pools of siGadd45alpha (M-042505-00), siGadd45 beta 
(M-040541-00), siGadd45 gamma (M-040263-00) and siGlow control (D-001600-01) 
were obtained from Dharmacon. 
5.2 General molecular methods 
Molecular biological techniques such as preparation of electrocompetent E.Coli (XL-
1 blue or SCS 110 strains) cells, transformation, plasmid preparation, restriction 
digestion, agarose gel electrophoresis of DNA, purification of DNA from gels have 
been performed according to standard methods (Joseph Sambrook and Russell, 2001) 
or according to the instructions of the manufacturers. DNA oligonucleotides for 
sequencing and PCR were synthesised by Qiagen . Sequencing of DNA samples were 
carried out by Dr. Hunziker of the central sequencing facility of the DKFZ. 
5.3 Screening of the libraries 
5.3.1 Screening of the Xenopus oocytes cDNA library 
1. Preparation of plasmid DNA pools of three hundred clones.  
i) 30 µl of the initial complete oocytes library is diluted 1:1000 by dissolving in 30 ml 
LB containing 6 g glycerol, mixed well and aliquoted into eppendorf tubes and stored 
at -80˚C.  
ii) The titre of the 1:1000 diluted library was estimated. Based on the titre, 1:1000 
diluted library was diluted further and spread on LB Amp plates so as to obtain 300 
colonies upon incubation for atleast 20 hours at 37˚C. 
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iii) The bacterial colonies were collected by adding 2.4 ml of LB and using a bacterial 
spreader the colonies were dissolved to an even suspension. 200 µl of this suspension 
was mixed with glycerol and was frozen. From the rest, plasmid DNA was prepared. 
Quality of each preparation was ensured by A260/280 >1.8. 330 such pools were 
prepared.  
2. Transfection: Generally, the cDNA pools were transfected into cells and observed 
after 48 hours. The choice of cells, modifications involving cotransfection of other 
constructs and reagents like Aza/TSA have been explained in the results section.  
3. Sib-selection 
 
Figure 28: Overview of screening of Xenopus oocytes cDNA library. 
 The oocytes library is not arrayed. Hence subpools had to be made for each round of 
screening. a) The library is diluted 1:1000 and stored at -80˚C. The titre of the diluted library 
was estimated; b) Plasmid DNA from 300 pooled bacterial clones was prepared; c) DNA 
pools were transfected into cells and Oct4 expression was read out; d) Glycerol stocks of all 
the positive pools were spread onto LB plates so as to get 100 bacterial clones; e) Plasmid 
DNA from 100 pooled bacterial clones was prepared; f) They were transfected and Oct4 
expression was read. This procedure could be repeated until a single clone is isolated or a 
similar strategy explained in the 5.3.2 could be used. 
The pools that activated Oct4 expression were scored as positive. The glycerol stocks 
of these pools were diluted; their titre was calculated and spread onto LB Amp plates 
so as to get 100 colonies after incubation. These colonies were collected by spreading 
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with LB. An aliquot was mixed with glycerol and frozen. The rest was used to obtain 
plasmid DNA. This was then transfected into cells and once again those pools (of size 
100) that activated Oct4 were selected. This procedure was repeated until a single 
clone was obtained. 
5.3.2 Screening of the XtSt10-30 cDNA expression 
library 
This library is made up of 11*96 well master plates and each well is a pool of  
plasmid DNAs from 96 bacterial clones. Glycerol stocks of these bacterial clones is 
also arrayed separately in a 96 well format. The library is transfected and positive 
pools were scored. The bacterial stock plate of the selected positive pools were 
replica-inoculated into two 96 well plates filled with LBAmp medium and grown at 
37 ˚C for 48 hours. From one of them, the bacterias were collected by pooling along 
the row so that 8 such pools - row pools-(made up of 12 clones each) were obtained. 
In the  another plate , the bacterias were pooled along the column so that 12 such 
pools -column pools-( made up of 8 clones each) were obtained. Plasmid DNAs were 
prepared from these 20 pools and transfected into cells. One would expect the clone 
of interest to be present in one of the 8 row pools as well as in one of the 12 column 
pools. The individual clone is spotted by the co-ordinates of the row-pool and that of 
the colum pool that activates the Oct4 expression after transfection into cells. 
5.3.3 Screening of the small molecules library 
The optimisation and methodology is explained in the results section.  
5.4 Reprogramming by using Xenopus laevis egg 
extracts 
5.4.1 Preparation of Xenopus laevis egg extracts 
Eggs were obtained by priming females with 600 IU human chorionic gonadotropin 
and were dejellied with 2% cysteine HCl. Eggs were washed two times with ice-cold 
extraction buffer (50 mM HEPES/KOH [pH 7.4], 50 mM KCl, 5 mM MgCl2, 2 mM 
β-mercaptoethanol, 5 mM EGTA, second wash including 10 µg/ml each cytochalasin 
B [Sigma, Munich, Germany], leupeptin, aprotinin, pepstatin A [all Calbiochem 
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Biosciences, La Jolla, CA]). Eggs or embryos were centrifuged at 1000 rpm for 1 min 
and transferred to 2 ml Eppendorf tubes after excessive buffer was carefully removed. 
Eggs and embryos were crushed by centrifugation at 10,000 × g for 15 min at 4°C. 
The middle layer was collected and recentrifuged at 16,000 × g to clear the extract. 
The extract was substituted with 2% glycerol, and aliquots were snap frozen in liquid 
nitrogen and stored at −80°C. 
5.4.2 Reprogramming experiment 
293T cells (1.5 × 10
6
 per reprogramming experiment) were harvested by flushing 
with PBS and transferred to 15 ml Falcon tubes. Cells were pelleted and resuspended 
in 0.5ml ice-cold transport buffer ( 20 mM HEPES [pH 7.3], 110 mM KAc, 5 mM 
NaAc, 2 mM MgAc, 1 mM EGTA, 2 mM DTT, 1 µg/ml each of aprotinin, pepstatin 
A, and leupeptin[protease inhibitors from Sigma] ). For reprogramming, cells were 
pelleted and resuspended in 0.5 ml transport buffer ± 17.5 µg/ml digitonin 
(Calbiochem) and incubated for 5 min on ice. Cells were washed in transport buffer, 
resuspended in 20 µl reprogramming mix (1 µl 20 mg/ml BSA [Roche], 1 µl 20 mM 
ATP, 1 µl 100 mM phosphocreatine, 1 µl 400 U/ml creatine kinase [all Sigma], 1 µl 
RNAsin [40 U/µl], 5 µl transport buffer, 10 µl egg extract) and incubated for 30 min 
at 37°C. Incubation was terminated by addition of 0.5 ml ice-cold transport buffer. 
293T cells were centrifuged, resuspended in cell culture medium, and cultivated in 4 
cm petri dishes at 37°C with 10% CO2. For the standard assay, spheres were 
harvested at day 5 (day 1 = experiment) 
5.5 Cell based assays 
5.5.1 Cell fusion 
HEK293 GoF-9 Luc cells and P19/pur cells were trypsinised and counted. They were 
mixed in the ratio 3:1 (HEK293: P19). The mixed cells were pelleted and then 
washed with plain DMEM medium. To the pellet, PEG 1500 solution (Roche) was 
added drop-by-drop very gently and then incubated for 3-4 minutes at 37˚C. The cells 
were washed in plain DMEM medium and resuspended in complete medium and then 
distributed in 2*20 cm plates. P19 and HEK293 cells mixed together but not fused by 
PEG was used as a negative control. After 48 hours, puromycin and G418 (Final 
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concentration Puro: 0.6 µg/ml and G418: 2 mg/ml) were added. The media was 
changed every alternate day until no cells survived in the negative control. Fusion 
Colonies obtained from experimental plates were divided into two for i)RT-PCR 
analysis and ii) luciferase assay. 
5.5.2 DNA transfections 
DNA transfections using Fugene6 (Roche) were done according to the manufacturer’s 
instructions. For maximal transfection efficiency, the volume of the transfection 
reagent to be used was optimised for each of the cell lines (Table IV). 
Cell lines Reagent / Method 
DNA (µg): transfection 
reagent (µl) 
HCT116Dnmt1
-/- 
cells Fugene 1:6 
HEK293 Fugene 1:3 
HEK293T Fugene 1:3 
NIH3T3 Fugene 1:6 
OctA/OctD cells Fugene 1:5 
OG2 fibroblasts Fugene 1:9 
P19 Fugene 1:5 
mES cells Electroporation   
Table IV: DNA transfection conditions used for different cell lines. 
 
5.5.3 Establishment of OG2 fibroblasts culture 
i) On day 14.5 of pregnancy, the OG2 mouse was sacrificed and rinsed with 70% 
ethanol.  
ii) The abdominal skin was opened and pinned to the side. The body was opened with 
new operating tools. 
iii) The whole uterus was taken out and put into a sterile 10 cm dish containing PBS. 
Under the cell culture hood, the embryos were removed from the uterus and placed 
into a new 10 cm-dish containing PBS. 
iv) Each embryo was cleaned off extra-embryonic tissue and debris. The liver was 
removed with a bowed pipette and the embryos were directly put into a clean 10 cm 
dish without any PBS. 
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v) The embryo was sheared into small fragments until a viscous solution was got. 5 
ml of trypsin EDTA was added and transferred with a cut-off blue tip to a conical 
flask with a magnetic stirrer. The contents were stirred for 10 minutes.  
vi) The supernatant was transferred to a falcon tube and the trypsin was inactivated 
with complete DMEM medium. This mixture was pipetted up and down and left aside 
for 10 minutes and then pelleted. The cells were resuspended with complete DMEM. 
Typically 10 ml of the medium was used for each of the embryos obtained. 
vii) Day 3: cells were transferred from 10-cm dish to one maxi dish 
viii) Day5: Each maxi-dish was split 1:3 
ix) Day 7: The cells were trypsin–EDTA digested and frozen in three cryovials per 
maxi plate. 
5.5.4 Differentiation of C2C12 cells 
C2C12 cells were plated in 6 well dishes. Typically 1*10
6
 cells are plated. 24 hours 
after culturing complete growth medium, the cells were washed with plain DMEM 
medium and then suspended in DMEM consisting of 2% HCS. The medium was then 
changed every alternative day. Typically after 4 days of induction, myotubes were 
seen.   
5.5.5 siRNA transfection in C2C12 cells 
Day -5: C2C12 cells were freshly thawed . 
Day -4: Thawed cells were expanded in 20 cm dishes .  
Day -2: These Passage 1 cells were trypsnised, counted and 1*10
5
 cells were 
suspended in complete DMEM without antibiotics in each well of a 6 well plate. 
After about 5-6 hours of plating, cells were transfected with siRNA. 120 nM siGlow 
Control or 40 nM siGadd45alpha or 40 nM siGadd45beta smart pools were 
suspended in antibiotic free 250 µl optiMEM. 8 µl Dharmafect3 is suspended in 250 
µl optimem. These siRNA and transfection reagents were mixed and incubated for 20 
minutes and then added to cells.  
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Day -1: After 24 hours of initial transfection, the medium is sucked away and the 
transfection of siRNAs is once again repeated . 
Day 0: Growth medium was removed and differentiation medium was added. 
Day +2: End of experiment 
To One well, 5 µM Aza was added and seved as a control. As the Aza is unstable at 
cell culture conditions, fresh Aza was added everyday during the course of the 
experiment. 
5.5.6 HpaII/MS multiplex PCR 
C2C12 cells were induced to differentiate as indicated above. Genomic DNA was 
isolated on day-2, day 0, day 2 of differentiation using the DNeasy blood & tissue kit 
(Qiagen). 500 ng genomic DNA was digested with HpaII or MspI overnight in a 20 µl 
enzymatic reaction. Undigested DNA served as a control. 2 µl of  each of them was 
used as a template in a multiplex PCR using Accuprime Taq polymerase system 
(Invitrogen) according to the program  
  95˚C, 3 minutes 
  94˚C, 45 seconds 
  62˚C, 45 seconds 
  68˚C, 45 seconds 
  -31 cycles- 
  68˚C, 2 minutes  
The products were then resolved by 1.5% Agarose gel. 
Primers used in MS-PCR of mMyogenin is listed in the table V. 
Purpose Primer ID and Sequence 
5’-flanking region  MyoP1 TGGAGTGGTCCTGATGTGGTAGTGG 
MyoM8 ACCCAGAGATAAATATAGCCAACGC 
 
Exon3, loading Control MyoP10 TCCATCGTGGACAGCATCACG 
MyoM2 TAAGGAGTCAGCTAAATTCCCTCGC 
 
Table V: Primers used in MS-PCR of mMyogenin. 
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5.5.7 Combined Bisulphite Restriction Analysis 
(COBRA)  
 
Background: 
 
The bisulphite treatment based methods for determining the methylation status of 
cytosine residues in a DNA molecule depend on the reaction of bisulphite with 
cytosines in single stranded DNA. Cytosines are converted to uracils (see Figure 29) 
whereas 5-methylcytosines (5-mC) are unreactive.  
                                 
Figure 29: Bisulphite reaction. 
Left panel: Basis of bisulphite modification; Right panel: a cartoon of cytosine and methyl 
cytosine 
The modified DNA strands can be amplified using Polymerase Chain Reaction 
(PCR). It is important that the primers used in the PCR reaction do not contain CpG 
dinucleotides so that the amplification step does not discriminate between templates 
according to their original methylation status. Because the Taq polymerase is 
permissive for uracil, it will incorporate thymine in the new synthesized strand in 
those positions in which a uracil was present in the template DNA molecule. This 
combination of bisulphite treatment and PCR amplification results in the conversion 
of unmethylated cytosine residues to thymine and methylated cytosine residues to 
cytosine. The PCR-product can be on one hand sequenced directly, or cloned and 
sequenced to give methylation data from single DNA molecules or in the other hand 
subjected to a restriction enzyme digestion as in COBRA (Combined Bisulphite 
Restriction Analysis). The methylation-dependent sequence conversion induced after 
bisulphite treatment and PCR amplification can lead to a loss of a pre-existing site 
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(thereby creating in some cases a new restriction enzyme site) or it can lead to a 
methylation-dependent retention of pre-existing sites.  
Basis of COBRA of 5'-flanking region of the Myogenin gene 
Genomic sequence M95800.1 myogenin nt 1191 - 1549  
accagctgccttggaccatggaggagagagtaggcaggaggcccgggtaggagtaattgaaaggagcagatgagacg
ggggaatgcacccacccccaccttccctgccccacaggntgtggagaaatgaaaactaatcaaattacagccgacggcc
tcccgacccgtgcacaggagccgcctgggccaggggcaggcctgcagggtggggtgggggcaaaaggagagggaa
ggggaatcacatgtaatccactggaaacgtcttgatgtgcagcaacagcttagaggggggctcaggtttctgtggcgttgg
ctatatttatctctgggttcatgccagcagggagggtttaaatggcac  
 
Keys:  
HpaII (this site was reported to be demethylated during differentiation) 
HpyCH4IV; Hpy99I  
The above 358bp region of the Myogenin gene is bisulphite converted and PCR 
amplified. CpGs in the Myogenin gene of C2C12 cells are expected to be methylated 
when cultured in the growth medium and undergo demethylation when the cells are 
induced to differentiate. If this is the case, bisulphite treatment should not modify 
CpGs in the undifferentiated state and hence the 358 bp region would yield two bands 
upon digestion with HpyCHIV or Hpy99I. Upon differentiation, CpGs would be 
demethylated and hence would be modified by bisulphite treatment thereby 
HpyCHIV or Hpy99I sites would be lost.  
Thus if a 358 bp product alone is obtained with HpyCHIV or Hpy99I digestion of 
bisulphite converted DNA, it indicates, Myogenin remains demethylated. If shorter 
digestion products are obtained, it indicates the methylation status of the myogenin 
gene. 
Brief protocol: 
i) siRNA was transfected into C2C12 cells as explained in chapter 5.5.5 and genomic 
DNA was isolated on day -2, day 0, day +2 using Dneasy blood & tissue kit. 
ii) Genomic DNA was bisulphite converted using Epitect Bisulphite kit (Qiagen) 
according to the manufacturer’s instructions. 
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iii) Efficiency of bisulphite conversion was ensured by absence of any PCR products 
using primers SK173 and SK174 that specifically recognises only unconverted DNA 
template. 
iv) Bisulphite converted DNA was used as a template and using primers SK171 and 
SK172, a 358 bp region of the myogenin gene (region 1191 to 1549 of the genbank 
accession number M95800.1) was amplified using Accumprime Taq polymerase 
system (Invitrogen) using 2.25mM Magnesium chloride and annealing at 56˚C. 
V). The obtained PCR product was then digested by using HpyCH4IV or Hpy99I and 
resolved by agarose gel electrophoresis. 
Primers used in COBRA of mMyogenin is listed in table VI  
 
Purpose Primers 
For Bisulphite converted DNA 
 
SK171 ATTAGTTGTTTTGGATTATGGAGGA 
SK172 TACCATTTAAACCCTCCCTACTAAC 
 
For unconverted DNA 
 
SK173  ACCAGCTGCCTTGGACCATGGAGGA 
SK174 TGCCATTTAAACCCTCCCTGCTGGC 
 
Table VI: Primers used in COBRA of mMyogenin. 
5.5.8 Reverse Transcription-Polymerase Chain 
Reaction  
RNA isolation 
i) From Spheroids obtained after nuclear reprogramming with Xenopus extracts: 
RNA can be obtained by CsCl method or by modified trizol protocol. 
CsCl method: Spheres, clusters, and cells were picked by observing under the 
microscope and transferred to 100 µl denaturing solution (4 M GnSCN, 0.5% 
sarcosinate, 1% β-mercaptoethanol, 20 µg rRNA), laid over 100 µl 5.7 M CsCl, and 
spun for 3.5hr at 174,000 × g in a TL-100 Tabletop Ultracentrifuge (Beckman 
Coulter, Fullerton, CA) using a TLA 100.2 rotor. The supernatant was discarded in 
several steps with new pipette tips to carefully avoid DNA contamination. The RNA 
pellet was washed in 70% EtOH, dried, resuspended in 20 µl DEPC-H2O and 
Materials and Methods 
87 
reprecipitated with sodium acetate. The washed and dried pellet was resuspended in 
DEPC-H2O. 
Trizol protocol: This method provides an easy option to isolate RNA from Spheres, 
clustures and cells. The protocol involves cell lysis using 1 ml of trizol and 
subsequent steps according to the manufacturer’s instructions and the following 
modifications: It is important to add RNase free glycogen as a carrier to precipitate 
the RNA. Isopropanol precipitation was done overnight at -20˚C. 
ii) From cell cultures: RNA was isolated by lysing by using Trizol method according 
to the manufacturers instructions.  
DNase digestion  
1µg of RNA      ` x µl 
10X DNAse buffer (Fermentas)   1.2 µl 
RNA guard (40 units/µl) (Fermentas)   0.5 µl 
DNase (Fermentas)     1 unit 
Final Volume adjusted with DEPC treated water to   12 µl 
Digestion was done at 37˚C for 40 minutes. 1 µl of 25 mM EDTA was added and 
incubated at 65˚C for 15 minutes.  
First Strand Synthesis: 
6 µl of DNase treated RNA was used for first strand synthesis. The rest was used for –
RT control. First strand synthesis was essentially done using Superscript II cDNA 
synthesis kit (Invitrogen). 
A 20 µl reaction volume can be used for 1 ng–5 µg of total RNA or 1–500 ng of 
mRNA. 
i) Following components were added to a nuclease-free microcentrifuge tube: 
Total RNA      6 µl 
Random primers (50 ng/µl)  2 µl 
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dNTP Mix (5 mM each)   2 µl 
Sterile, distilled water to            12 µl 
ii) Incubated the mixture to 65°C for 5 min and quick chilled on ice. The contents of 
the tube were collected by brief centrifugation and added: 
5X First-Strand Buffer             4 µl 
0.1 M DTT                2 µl 
RNA guard (40 units/µl)                     1 µl 
iii). Mixed the contents of the tube gently and incubated at 25°C for 2 min. 
IV) Added 1 µl (200 units) of SuperScript II RT and mix by pipetting gently up and 
down. The cDNA was synthesized by incubating the tubes at 25°C for 10 min; then at 
42°C for 90 min. The reaction was inactivated by heating at 70°C for 15 min. The 
cDNA can now be used as a template for amplification in PCR or Real time PCR.  
RT-PCR 
i) The PCR reactions were mixed on ice in 0.5 µl PCR tubes (master mix was 
prepared): 
10X PCR Buffer (Perkin-Elmer)   5.0 µl 
2 mM dNTP Mix      2.5 µl 
Forward primer (10 µM)     1.0 µl 
Reverse primer (10 µM)     1.0 µl 
Taq DNA polymerase (home made)                0.5 µl 
cDNA from first-strand reaction                     1.0 µl 
 autoclaved, distilled water to                          25.0 µl 
ii) The RT-PCR settings were 
95˚C, 1 minute 
55˚C-62˚C (varies for each primer pair), 1 minute 
72˚C, 1 minute 
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18-45 cycles depending on the target 
72˚C, 10 minutes 
20˚C, 10 minutes 
iii) After the PCR, 5 µl of 6X loading dye was added and then 15 µl of the mixture 
was loaded onto 1.5-2% agarose gel, separated at 6 V/cm for 30 min and visualized 
with ethidium bromide staining. Normalisation of the cDNA samples was performed 
according to Beta actin levels. PCR cycle numbers were optimized to be in the linear 
range of amplification. The primers used for RT-PCR are listed in table VII: 
 
Table VII: RT-PCR primers. 
Real Time PCR using UPL Probes: 
For Real-Time PCR employing UPL probes, the Roche LightCycler480 Probes 
Master was used. This Master mix is 2x concentrated and contains a Hot Start Taq 
Polymerase and dNTPs. Typically 20 µl reaction was performed in triplicates.  
Setting up of the reaction (1x): 
Gene  Primer ID and Sequence 
Beta actin(Human and 
Mouse orthologs) 
E270 GACCCAGATCATGTTTGAGACC 
E271 AGGTCCAGACGCAGGATG 
 
 hBeta actin Mao20 GCTATCCCTGTACGCCTCTG 
Mao21 CCATCTCTTGCTCGAAGTCC 
 
SK104  CATTCCAAATATGAGATGCATTG   
SK106  CACGAAGGCTCATCATTCAA       
 
mBeta actin mBA1 GTGGGCCGCTCTAGGCACCAA 
mBA2 CTCTTTGATGTCACGCACGATTTC 
 
hOct4 SK14 GACAACAATGAAAATCTTCAGGAGA 
SK15 TTCTGGCGCCGGTTACAGAACCA 
 
mOct4 SK12 TGCTGGAGAAGTGGGTGGAGG 
SK13 GTAGAGTGTGGTGAAGTGGGGG 
 
hRex-1 SK18 GCGTACGCAAATTAAAGTCCAGA 
SK19 CAGATCCTAAACAGCTCGCAGAAT 
 
hGCAP GCAP-1 CCATATCCTGAGGTGGATCAG 
GCAP-2 CAGGGAGGGAAGGTAATGAGT 
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2x PROBES Master    10.0 µl 
Primer Mix       1.0 µl 
(forward + reverse, 10µM each) 
UPL probe       0.2 µl 
cDNA template         x µl 
ddH20 add       20 µl 
Precautions: 
• The UPL probe is light sensitive! Do not expose to light for longer periods!! 
• Real-Time PCR is generally very sensitive! To avoid deviations because of 
variations in the pipetting volume, dilute your DNA template and use higher volume 
(optimally 2-5 µl) 
PCR plates: Special 96 Well plates are used for Real-Time PCR as the conventional 
plates often show an intrinsic fluorescence which affects the fluorescence acquisition. 
After pipetting the plate was centrifuged for 3 min at 2000 rpm in a swing out rotor to 
remove air bubbles. 
PCR-Program 
Step I: denaturation (HotStart Taq) 95°C, 5-10 minutes 
Step II: amplification, 40-50cyc 95°C, 10 seconds 
Annealing Temperature, 15-30 seconds 
72°C, 1 second Acquisition* 
3rd cooling, 40°C 10 seconds 
* After every round of elongation the fluorescence is measured by the LightCycler. 
Amount of fluorescence is monitored in Real-Time so that you can follow up the 
amplification. Melting curve has not to be performed using this format. Values can 
direcly be used for analysis. Typically a standard curve was generated for each primer 
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pair being used using a template that the primer pair could successfully amplify. 
Primers used in the Real time PCR are described in the table VIII 
Gene Primer ID and Sequence UPL 
Probe 
ID 
mBeta actin SK157 AAGGCCAACCGTGAAAAGAT 
SK158 GTGGTACGACCAGAGGCATAC 
 
56 
mGADD45alpha 
 
SK159 GCTGCCAAGCTGCTCAAC 
SK160 TCGTCGTCTTCGTCAGCA 
 
40 
mGADD45beta 
 
SK161 CGGCCAAACTGATGAATGT 
SK162 ATCTGCAGAGCGATATCATCC 
 
79 
mGADD45gamma 
 
SK163 CCGTGGCCAGGATACAGTT 
SK164 AAGTTCGTGCAGTGCTTTCC 
 
76 
mMyogenin SK165 CCTTGCTCAGCTCCCTCA 
SK166 TGGGAGTTGCATTCACTGG 
 
63 
Table VIII: Real time PCR primers. 
5.5.9 Luciferase assay 
Luciferase assays reporter assays in P19 and HCT116Dnmt1
-/-
 cells were carried out 
in 96 well plates in triplicates with a volume of 50 µl per well. Firefly and Renlla 
luciferase activities were measured using the Dual Luciferase Assay Kit (Promega) on 
the Fluroskan Ascent FL (Labsystems). The Firefly luciferase activity was normalized 
against Renilla luciferase activity. In case of  mES cells and  fusion colonies, the cells 
were lysed in passive lysis buffer and equal amounts of protein in control and 
experimental samples were taken for analysis. For small molecule screening in 
HEK293/GoF-9 Luc clonal cell line 11, ATPLITE (PerkinElmer) was used to measure 
the luciferase readout. 
5.5.10 Beta-galactosidase staining 
OctD cells were rinsed with 0.5 ml of PBS and fixed with 0.5% glutaraldehyde in 
PBS at room temperature for 5 minutes. The cells were then rinsed two times with 
PBS and incubated for 15 minutes in 0.1% Triton X 100 diluted in PBS. 0.5 ml of 
staining solution per well (5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, 2 mM MgCl2, 0.25 
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mg/ml X-Gal in PBS). The cells were incubated until blue staining was visible and 
then rinsed several times with PBS. 
5.6 Protein methods 
5.6.1 Cell lysis 
Tissue culture cells were washed with PBS on ice and the cells were lysed with NOP 
buffer [2% NP-40,150 mM NaCl, 20 mM Tris, 2 mM PMSF and 1X protease 
inhibitory cocktail (Roche)] and the spinned at maximum speed at 4˚C to remove the 
debris and stores at -20˚C.  
5.6.2 Protein concentration estimation (BCA Method) 
The protein to be analyzed reacts with Cu
2+
 in an alkaline solution to make Cu
1+
 ions. 
These Cu
1+
 ions are then chelated by the BCA which converts the apple-green color 
of the free BCA to the purple color of the copper-BCA complex. This can be 
quantitatively measured at 562 nm. The complex is quite linear with increasing 
protein concentration over a working range of 20 mg/ml to 2000 mg/ml.  
BSA was used to gernerate a standard curve. Different dilutions of BSA and protein 
to be measured were incubated with 1 ml of 1:50 copper sulphate (4% v/v): BCA 
solution and incubated at 37˚C by vortexing for about 15 minutes. The samples were 
measured using spectrophotometer. 
5.6.3 SDS-PAGE and Western Blotting 
SDS-PAGE and western Blotting were carried out according to standard protocols 
(Joseph Sambrook and Russell, 2001)and signals were detected by enhanced 
chemiluminescence (Pierce). 
5.6.4 Immunostaining 
Cells were grown in 24 well plates. They were washed twice with PBS and fixed with 
paraformaldehyde. The cells were rinsed with PBS and incubated in a blocking 
solution made up of 1% BSA in PBS for 1 hour. The cells were then incubated with 
primary antibody overnight at 4˚C. After extensive washing the cells were incubated 
Materials and Methods 
93 
for 1 hour in secondary antibody. The cells were washed and observed under 
microscope.  
5.7 Bioinformatic tools  
Genomic sequences were extracted from the public databases NCBI 
(www.ncbi.nih.gov) and the Sanger centre (www.ensembl.org). Sequence searches 
and comparisons were performed with BLAST (www.ncbi.nlm.nih.gov/BLAST). 
Primer design and sequence analyses were carried out with the integrated 
bioinformatic package HUSAR (http://genome.dkfz-heidelberg.de). Literature 
searches were done with PubMed (www.pubmed.gov). Real time PCRs primers and 
their UPL probes were obtained from https://www.roche-applied-
science.com/sis/rtpcr/upl/adc.jsp 
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